MMAT Meta Materials Inc

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 001-36247

Meta Materials Inc.

(Exact Name of Registrant as Specified in its Charter)

 

Nevada	74-3237581
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
60 Highfield Park Drive Dartmouth, Nova Scotia, Canada	B3A 4R9
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (902) 482-5729

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.001 per share	MMAT	Nasdaq Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 10, 2024, the registrant had 6,695,536 shares of common stock, $0.001 par value per share, outstanding, including the Exchangeable Shares of 368,118.

---

Exchangeable Shares:

The exchangeable shares are shares of the share capital in Metamaterial Exchangeco Inc., a wholly-owned subsidiary of the Registrant (the "Exchangeable Shares"). The exchangeable shares are publicly traded on the Canadian Securities Exchange under the symbol MMAX. These shares are intended to provide substantially the same economic and voting rights as the Registrant’s common stock in which they may be exchanged. The Registrant also has issued and outstanding one share of Series B Special Voting Preferred Stock (the “Series B Special Voting Preferred Stock”). The Series B Special Voting Preferred Stock provides the mechanism for holders of exchangeable shares to be provided instructions to vote with the holders of the common stock. The holder of the Series B Special Voting Preferred Stock is entitled to one vote for each outstanding exchangeable share and generally votes together with the common stock on all matters on which holders of the common stock are entitled to vote. The Series B Special Voting Preferred Stock is subject to a voting trust arrangement. The trustee which holds the Series B Special Voting Preferred Stock is required to cast a number of votes equal to the number of then-outstanding exchangeable shares, but will only cast a number of votes equal to the number of exchangeable shares as to which it has received voting instructions from the owners of record of those exchangeable shares, other than the Registrant or its subsidiaries, respectively, on the record date, and will cast the votes in accordance with such instructions so received.

 

 

---

TABLE OF CONTENTS

FORWARD-LOOKING STATEMENTS	3
PART I—FINANCIAL INFORMATION	5
Item 1. Financial Statements	5
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	24
Item 3. Quantitative and Qualitative Disclosures About Market Risk	31
Item 4. Controls and Procedures	31
PART II—OTHER INFORMATION	33
Item 1. Legal Proceedings	33
Item 1A. Risk Factors	33
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	33
Item 3. Defaults Upon Senior Securities	33
Item 4. Mine Safety Disclosures	34
Item 5. Other Information	34
Item 6. Exhibits	35
SIGNATURES	36

 

---

FORWARD-LOOKING STATEMENTS

This Quarterly Report on Form 10-Q ("Quarterly Report") contains forward-looking statements within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements contained in this Quarterly Report include statements about:

We caution you that the foregoing list may not contain all of the forward-looking statements made in this Quarterly Report.

You should not rely upon forward-looking statements as predictions of future events. We have based these forward-looking statements contained in this Quarterly Report largely on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operations, business strategy, short-term and long-term business operations and objectives and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in Part I, Item 1A, "Risk Factors" of our Annual Report on Form 10-K for the year ended December 31, 2023 (the “Annual Report”), this Quarterly Report, and in our other filings we make with the Securities and Exchange Commission ("SEC"). Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for us to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

The forward-looking statements made in this Quarterly Report relate only to events as of the date on which the statements are made. We undertake no obligation to update any forward-looking statements made in this Quarterly Report to reflect events or circumstances after the date of this Quarterly Report or to reflect new information or the occurrence of unanticipated events, except as required by law. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place

---

undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact of any future acquisitions, mergers, dispositions, joint ventures or investments we may make.

In addition, statements that “we believe” and similar statements reflect our beliefs and opinions on the relevant subject. These statements are based upon information available to us as of the date of this Quarterly Report, and while we believe such information forms a reasonable basis for such statements, such information may be limited or incomplete, and our statements should not be read to indicate that we have conducted an exhaustive inquiry into, or review of, all potentially available relevant information. These statements are inherently uncertain and investors are cautioned not to unduly rely upon these statements.

---

PART I—FINANCIAL INFORMATION

Item 1. Financial Statements

META MATERIALS INC.

CONDENSED CONSOLIDATED INTERIM BALANCE SHEETS (UNAUDITED)

 

		As of March 31,				As of December 31,
		2024				2023
Assets
Current assets:
Cash and cash equivalents		$	6,395,929			$	9,723,690
Restricted cash			564,576				578,406
Accounts receivables			2,048,426				942,793
Subscription receivables			—				881,100
Inventory			123,877				168,747
Prepaid expenses and other current assets			1,587,492				5,071,363
Due from related parties			—				29,906
Total current assets			10,720,300				17,396,005
Intangible assets, net			16,936,346				18,030,301
Property, plant and equipment, net			17,848,873				18,601,614
Operating lease right-of-use ("ROU") assets			855,641				1,200,417
Total assets		$	46,361,160			$	55,228,337
Liabilities and stockholders’ equity
Current liabilities:
Trade payables		$	9,696,923			$	10,270,386
Accruals and other payables			3,841,799				7,249,291
Restructuring costs accrual			1,008,924				1,182,112
Current portion of long-term debt			545,215				801,628
Current portion of deferred revenues			665,955				1,054,557
Current portion of deferred government assistance			566,647				590,954
Current portion of funding obligation			959,410				982,912
Current portion of operating lease liabilities			1,296,404				1,452,863
Total current liabilities			18,581,277				23,584,703
Deferred revenues			384,876				419,035
Deferred government assistance			428,861				391,148
Long-term operating lease liabilities			5,671,681				5,973,657
Long-term debt			2,959,082				2,922,989
Total liabilities			28,025,777				33,291,532
Commitments and contingencies (Note 19)
Stockholders’ equity
Common stock - $0.001 par value; 10,000,000 shares authorized, 6,694,635 shares issued and outstanding at March 31, 2024, and $0.001 par value; 10,000,000 shares authorized, 5,659,438 shares issued and outstanding at December 31, 2023			6,694				543,046
Treasury stock, at cost, 18,536 shares at March 31, 2024 and 0 shares at December 31, 2023			(123,859	)			—
Additional paid-in capital			639,618,677				635,860,437
Accumulated other comprehensive loss			(4,646,182	)			(5,455,145	)
Accumulated deficit			(616,519,947	)			(609,011,533	)
Total stockholders’ equity			18,335,383				21,936,805
Total liabilities and stockholders’ equity		$	46,361,160			$	55,228,337

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

---

META MATERIALS INC.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (UNAUDITED)

		Three months ended March 31,
		2024				2023
Revenue:
Product sales		$	85,169			$	58,699
Development revenue			3,141,759				1,257,479
Licensing revenue			45,329				96,081
Total revenue			3,272,257				1,412,259
Cost of sales (exclusive of items shown separately below)			778,266				587,028
Depreciation and amortization expense included in cost of sales			3,673				10,047
Stock-based compensation expense (recovery) included in cost of sales			(48,417	)			143,905
Gross profit			2,538,735				671,279
Operating expenses:
Sales & marketing			332,964				2,307,353
General & administrative			3,926,643				6,769,437
Research & development			2,660,995				5,060,756
Depreciation & amortization expenses			991,625				3,234,495
Stock-based compensation expense			310,825				1,858,440
Restructuring expense			266,035				—
Total operating expenses			8,489,087				19,230,481
Loss from operations			(5,950,352	)			(18,559,202	)
Interest expense, net			(108,766	)			(112,998	)
Realized gain (loss) on foreign exchange, net			62,445				(40,689	)
Unrealized gain (loss) on foreign exchange, net			(1,513,055	)			325,600
Other income (expense), net			1,314				(578,120	)
Total other expense, net			(1,558,062	)			(406,207	)
Loss before income taxes			(7,508,414	)			(18,965,409	)
Income tax recovery			—				296,731
Net loss		$	(7,508,414	)		$	(18,668,678	)
Other comprehensive loss, net of tax
Unrealized foreign currency translation gain			808,963				322,787
Total other comprehensive income			808,963				322,787
Comprehensive loss		$	(6,699,451	)		$	(18,345,891	)
Basic and diluted loss per share		$	(1.21	)		$	(5.06	)
Weighted average number of shares outstanding - basic and diluted			6,180,363				3,688,793

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

---

META MATERIALS INC.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)

 

																					Accumulated
																	Additional				Other								Total
	Common Stock								Treasury								Paid-in				Comprehensive				Accumulated				Stockholders’
	Shares (1)				Amount				Shares (1)				Amount				Capital				Income (loss)				Deficit				Equity
Balance, January 1, 2024		5,659,438			$	543,046				—			$	—			$	635,860,437			$	(5,455,145	)		$	(609,011,533	)		$	21,936,805
Reverse stock split fractional shares adjustment		177,686				(537,210	)			—				—				537,210				—				—				—
Net loss		—				—				—				—				—				—				(7,508,414	)			(7,508,414	)
Other comprehensive income		—				—				—				—				—				808,963				—				808,963
Issuance of common stock and warrants		600,000				600				—				—				3,433,150				—				—				3,433,750
Stock issuance costs		—				—				—				—				(659,851	)			—				—				(659,851	)
Exercise of warrants		250,000				250				—				—				—				—				—				250
Settlement of restricted stock units		7,511				8				(19	)			(164	)			(8	)			—				—				(164	)
Stock-based compensation		—				—				—				—				262,408				—				—				262,408
Fair value adjustments of June 2022 Warrants and December 2023 Warrants		—				—				—				—				185,331				—				—				185,331
18,517 shares originally purchased by Mr. McCabe which were reassigned to META upon termination of SPA		—				—				(18,517	)			(123,695	)			—				—				—				(123,695	)
Balance, March 31, 2024		6,694,635			$	6,694				(18,536	)		$	(123,859	)		$	639,618,677			$	(4,646,182	)		$	(616,519,947	)		$	18,335,383
Balance, January 1, 2023		3,622,479			$	340,425				—			$	—			$	590,962,866			$	(5,242,810	)		$	(207,496,328	)		$	378,564,153
Net loss		—				—				—				—				—				—				(18,668,678	)			(18,668,678	)
Other comprehensive income		—				—				—				—				—				322,787				—				322,787
Issuance of common stock		175,740				17,574				—				—				10,459,495				—				—				10,477,069
Stock issuance costs		—				—				—				—				(438,785	)			—				—				(438,785	)
Exercise of stock options		26,342				2,634				—				—				708,612				—				—				711,246
Settlement of restricted stock units		12,888				1,289				—				—				(1,289	)			—				—				—
Stock-based compensation		—				—				—				—				2,002,340				—				—				2,002,340
Balance, March 31, 2023		3,837,449			$	361,922				—			$	—			$	603,693,239			$	(4,920,023	)		$	(226,165,006	)		$	372,970,132

(1) In accordance with SAB Topic 4.C, all number of shares have been adjusted retroactively to reflect the Reverse Stock Split on January 29, 2024.

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

---

META MATERIALS INC.

CONDENSED CONSOLIDATED INTERIM STATEMENTS OF CASH FLOWS (UNAUDITED)

 

		Three months ended March 31,
		2024				2023
Cash flows from operating activities:
Net loss		$	(7,508,414	)		$	(18,668,678	)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense			119,985				137,657
Non-cash interest income			—				(391,111	)
Non-cash lease expense			303,336				401,528
Deferred income tax			—				(296,731	)
Depreciation and amortization expense			995,298				3,244,511
Credit loss expense			—				981,861
Unrealized foreign currency exchange (gain) loss			1,520,386				(221,535	)
Change in deferred revenue			(399,220	)			(4,580	)
Stock-based compensation and other non-cash personnel expense			262,408				2,002,343
Others			57,406				18,843
Changes in operating assets and liabilities			(1,273,949	)			(2,724,270	)
Net cash used in operating activities			(5,922,764	)			(15,520,162	)
Cash flows from investing activities:
Purchases of property, plant and equipment			(115,995	)			(1,693,768	)
Proceeds from below-market capital government loan			148,091				256,240
Proceeds from collection of Next Bridge Notes Receivable			—				1,000,000
Net cash provided by (used in) investing activities			32,096				(437,528	)
Cash flows from financing activities:
Proceeds from the issuance of common stock and warrants			3,433,750				10,477,069
Stock issuance costs paid on the issuance of common stock and warrants			(418,372	)			(438,785	)
Repayments of long-term debt			(362,760	)			(85,457	)
Proceeds from stock option and warrants exercises			250				711,246
Repurchases of common stock for income tax withheld upon settlement of restricted stock units			(164	)			—
Net cash provided by financing activities			2,652,704				10,664,073
Net decrease in cash, cash equivalents and restricted cash			(3,237,964	)			(5,293,617	)
Cash, cash equivalents and restricted cash at beginning of the year			10,302,096				11,811,471
Effects of exchange rate changes on cash, cash equivalents and restricted cash			(103,627	)			23,769
Cash, cash equivalents and restricted cash at end of the period		$	6,960,505			$	6,541,623
Supplemental cash flow information
Accrued purchases of property, equipment and patents		$	16,689			$	1,998,469
ROU assets derecognized from termination of operating lease obligations		$	250,878			$	—
Common stock issuance costs in accrued liabilities or accounts payable		$	56,150			$	—
Non-cash issuance costs as a result of amendment of June 2022 Warrants and December 2023 Warrants		$	185,331			$	—
18,517 shares originally purchased by Mr. McCabe which were reassigned to META upon termination of SPA		$	123,695			$	—

The accompanying notes are an integral part of these condensed consolidated interim financial statements.

---

META MATERIALS INC.

NOTES TO CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS (Unaudited)

5. Notes Receivable

 

---

7. Prepaid Expenses and Other Current Assets

 

8. Property, Plant and Equipment, net

9. Intangible Assets and Goodwill

---

 

 

 

 

 

 

 

---

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations should be read in conjunction with our condensed consolidated interim financial statements and related notes thereto included in Part I, Item I (Financial Statements) of this Quarterly Report. For additional information regarding our financial condition and results of operations, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in Part II, Item 7 in our Annual Report, as well as our consolidated financial statements and related notes thereto included in Part II, Item 8 of the Annual Report. As discussed in the section titled “Forward-Looking Statements,” the following discussion contains forward-looking statements that involve risks and uncertainties. Factors that could cause or contribute to such differences include those identified below and those discussed in Part I, Item 1A (Risk Factors) in our Annual Report, and Part II, Item 1A (Risk Factors) and other parts of this Quarterly Report. Our historical results are not necessarily indicative of the results that may be expected for any period in the future.

OVERVIEW

Meta Materials Inc. (also referred to herein as the “Company”, “META”, “we”, “us”, or “our”) is an advanced materials and nanotechnology company. We are developing materials that we believe can improve the performance and efficiency of many current products as well as allow new products to be developed that cannot otherwise be developed without such materials as noted in the examples below. We develop new products and technologies using innovative sustainable science. We have product concepts currently in various stages of development with multiple potential customers in diverse market verticals. Our business model is to co-develop innovative products or applications with industry leaders that add value. This approach enables us to understand market dynamics and ensure the relevance and need for our products. META® technology platforms enable global brands to develop new products to improve performance for customers in aerospace and defense, consumer electronics, 5G communications, batteries, authentication, automotive and clean energy. For example, our QUANTUM™ stripe anti-counterfeiting security features for currency display full color, motion, and 3-D depth from an ultrathin, single layer of aluminum, without using any inks or dyes. Our NANOWEB® EMI shielding can block harmful microwaves while admitting more than 95% of visible light, enabling a crystal-clear window on a microwave oven door. We currently have over 455 active patent documents, of which 346 patents have issued. Our patent portfolio is comprised of 124 patent families, of which 73 include at least one issued patent.

Our principal executive office is located at 60 Highfield Park Drive, Suite 102, Dartmouth, Nova Scotia, Canada.

On June 6, 2023, our board of directors approved the Realignment and Consolidation Plan pursuant to which we have begun, but not yet completed, a process for increased focus on key applications with the greatest near-term revenue potential, and of realignment of our resources and structure for reduced operating expenses. Our focus applications include authentication, wide area motion imagery, battery materials, and transparent conductive films. As part of this plan, we are exploring alternatives for certain of our technologies including Holography, Wireless Sensing, and Radio Wave Imaging. These alternatives may include divesting, entering into a joint venture and/or curtailing our investments in these technologies.

Overall, our revenue had an increasing trend throughout the year ended December 31, 2023 and continued to increase through March 31, 2024. Especially, our revenue in the first quarter ended March 31, 2024 increased by $0.9 million, or 40.9%, compared to the fourth quarter ended December 31, 2023, and increased by $1.9 million, or 131.7%, compared to the first quarter ended March 31, 2023.

As a result of our effort to reduce our operating expenses as part of Realignment and Consolidation Plan, our operating expenses during the first quarter ended March 31, 2024 decreased by $73.4 million, or 89.4%, compared to the fourth quarter ended December 31, 2023. The decrease was mainly due to a $65.6 million impairment of long-term assets recorded in the fourth quarter ended December 31, 2023, a $2.5 million decrease in General and administrative expense, a $2.5 million decrease in Depreciation and amortization expenses, a $1.4 million decrease in Restructuring expenses and a $1.3 million decrease in Research and development expenses.

Recent Developments

Workforce reduction

On May 2, 2024, our board of directors approved a reduction in our workforce by approximately 80% of our employees (the “Workforce Reduction”) in order to preserve cash resources. The Workforce Reduction is expected to be completed over the next few weeks.

We continue to evaluate all available strategic alternatives including, but not limited to, the divestiture of assets, additional financing security and/or the sale of the Company. There can be no assurance regarding the outcome of this process. Without an influx of cash to support operations, we face financial hardship that may result in shuttering facilities and/or bankruptcy proceedings.

Reverse stock split

On January 29, 2024, we effected a reverse stock split of our common stock at a rate of 1-for-100. The Reverse Stock Split was approved by the board of directors in accordance with Nevada law. The Reverse Stock Split did not have any impact on the par value of our common stock. Unless otherwise indicated, all issued and outstanding shares of common stock and all outstanding securities entitling their holders to purchase shares of our common stock or acquire shares of our common stock, including stock options, restricted stock

---

units, and warrants, per share data, share prices and exercise prices, as required by the terms of those securities, were adjusted retroactively to reflect the Reverse Stock Split.

SEC investigation

In September 2021, we received a subpoena from the SEC in a matter captioned In the Matter of Torchlight Energy Resources, Inc. On July 20, 2023, the enforcement staff of the SEC provided us and our former officers with Wells Notices relating to the investigation. The Wells Notices state that the SEC staff has made a preliminary determination to recommend that the SEC file a civil enforcement action against the recipients alleging violations of certain provisions of the U.S. federal securities laws.

In response, we proposed a settlement, subject to SEC Commissioners' approval, which includes a $1.0 million penalty to be paid in installments over a year. This settlement does not involve admitting or denying the allegations. See Note 19, Commitments and Contingencies, Legal Matters, in the notes to the unaudited condensed consolidated interim financial statements in this Quarterly Report for further information.

Nasdaq minimum bid price compliance

On March 20, 2023, we were notified by Nasdaq of our failure to meet the minimum bid price criterion due to our common stock's closing bid price falling below $1.00 for 30 consecutive trading days. We were initially granted a 180-day compliance window, which was subsequently extended for another 180 days until March 18, 2024. Further, on November 27, 2023, a notification from Nasdaq indicated an intention to delist the Company's common stock due to its closing bid price being $0.10 or less for ten consecutive trading days. We promptly appealed this determination, leading to a hearing schedule revision by the Nasdaq Hearings Panel. On February 12, 2024, following our implementation of the 1-for-100 Reverse Stock Split, we were informed of our regained compliance with the Minimum Bid Price Requirement, eliminating the need for a hearing and affirming our status in compliance with Nasdaq listing standards. See Risk Factors in the Annual Report filed with the SEC on March 28, 2024 concerning Nasdaq listing standard compliance.

Sale of Next Bridge Notes Receivable

On August 7, 2023, a Loan Sale Agreement was entered with Gregory McCabe, under which we sold all rights and interests in the loans from Next Bridge Hydrocarbons Inc., which was previously a wholly-owned subsidiary of META, for $6.0 million in cash. Concurrently, we entered into a Stock Purchase Agreement ("SPA") in which Mr. McCabe agreed to buy $6.0 million of our common stock beginning on September 1, 2023, in monthly amounts of $250,000 for the first six months and in monthly amounts of $500,000 for the next nine months thereafter, at a price per share equal to 120% of the 5-day Volume-Weighted Average Price ("VWAP") on the trading day preceding the date of each such purchase.

On January 21, 2024, we entered into the Release Agreement with Mr. McCabe, pursuant to which we and Mr. McCabe agreed to terminate the SPA. See Note 5, Notes Receivable, in the notes to the unaudited condensed consolidated interim financial statements of this Quarterly Report for further details.

February 2024 offering

On February 21, 2024, we completed a registered direct offering with an institutional investor of (i) 600,000 shares of our common stock, (ii) pre-funded warrants to purchase up to 250,000 shares of common stock (the “Pre-Funded Warrants”), and (iii) warrants to purchase up to an aggregate of 850,000 shares of common stock (the “February 2024 Warrants”). Each share of common stock and Pre-Funded Warrant was offered and sold together with an accompanying February 2024 Warrant at a combined price of $4.04 per share of common stock or $4.039 per Pre-Funded Warrant, as applicable.

In connection with the February 2024 Offering, we received net proceeds of approximately $3.0 million, after deducting placement agent fees and estimated offering expenses payable by us.

On February 19, 2024, in connection with, and as a condition to, the February 2024 Offering, we executed a letter agreement (the "Letter Agreement") with the institutional investor participating in the February 2024 Offering. Under this agreement, we consented to modify certain terms of the June 2022 Warrants and the December 2023 Warrants (defined in Note 11, Capital Stock, in the notes to the unaudited condensed consolidated interim financial statements of this Quarterly Report) held by the investor. See Note 11, Capital Stock, in the notes to the unaudited condensed consolidated interim financial statements of this Quarterly Report for further details.

Known Trends and Uncertainties:

Capital reallocation and core business expansion

In line with our strategic refocusing, we have been shifting capital toward the core-business units that are expected to contribute to near-term cash flow, while simultaneously scaling back investments in non-core areas. This reallocation underscores our commitment to optimizing resource distribution, prioritizing the expansion and advancement of infrastructure integral to our core market offerings, which we believe are positioned to support our liquidity profile. This includes new facilities in Maryland for Electro-Optics and Infra-Red development and in Massachusetts for the Battery Materials development. These activities require capital investments and increased overhead for leased facilities in the future. Further, R&D expense related to our core business is expected to increase as a result of

---

expanding operations of our core business. The timing of new customer programs and revenues associated with these expansions is uncertain and we may require additional financing to support the related cash consumption.

Inflation

Inflation in North America, with respect to labor costs and transportation costs in particular, could elevate our costs of hiring new team members and cause increases in our labor costs for existing team members. In addition, rising transportation costs are likely to increase our costs for shipping our products and the costs associated with our material purchases.

Vehicle electrification

The transition from internal combustion engine, or ICE, vehicles to electric vehicles, or EVs, may be accelerated by recent disruptions in global oil supply, reduced investment in new domestic oil exploration, and increased government support for domestic EV production, battery and battery materials supply chain, and EV charging infrastructure. This may increase the opportunity for META to scale up battery materials production, acquire new battery component customers, and obtain government funding for capital projects. It could also accelerate demand for certain of our NANOWEB® products targeting EVs.

Expanding focus and emphasis on information technology

With the rapid growth of our global business, our data protection and cyber security needs have become a significant element of our business. Failure on our part to invest in the tools, equipment and personnel required to adequately manage these elements could result in regulatory issues, claims by customers and potential financial liabilities. Further, customer prospects identifying such failures could decide to delay or abandon orders from us.

NANOWEB® capacity

Our NANOWEB® products have not yet reached the required manufacturing scale to enable us to address the volume demands of a number of our target vertical markets. We must either design, develop and procure additional internal capacity to produce NANOWEB® films in higher volume and larger formats or identify outsourced suppliers capable of producing our designs. During the year ended December 31, 2023, we have engaged in a strategic partnership with Panasonic Industry to enhance the production volume of NANOWEB® films and accelerate the growth of the transparent conductive film market, offering new applications for the automotive and consumer electronics industries.

Foreign currency fluctuation risk

As we continue to expand our business globally, we presently have currency exposure arising from both sales and purchases denominated in foreign currencies. We currently do not utilize derivative financial instruments, forward contracts, or any other financial instruments designed to hedge against potential fluctuations in foreign currency exchange rates. Fluctuations in the value of currencies, such as Canadian Dollar, British Pound and Euro against the US Dollar could adversely impact our revenue and operating and labor costs. In addition, items included in the financial statements of the Company and its subsidiaries are measured using the currency of the primary economic environment in which the entity operates (the “functional currency”) while our reporting currency is the US Dollar. As such, our financial results and positions are exposed to changes in exchange rates between the US Dollar and the Canadian Dollar, the British Pound, and the Euro. For the three months ended March 31, 2024, almost all of our consolidated revenue and 48.1% of operating expenses were recorded in our entities which functional currency is other than US Dollar and approximately 52.9% of Cash and Cash equivalent, 100% of Property and Equipment, and 32.4% of Accounts Payable and Accruals were recorded in such entities which functional currency is other than US Dollar.

Basis of Presentation

The following discussion highlights our results of operations and the principal factors that have affected our financial condition as well as our liquidity and capital resources for the periods described and provides information that management believes is relevant for an assessment and understanding of the condensed consolidated interim balance sheet and statements of operation and comprehensive loss presented herein. The following discussion and analysis are based on our condensed consolidated interim financial statements contained in this Quarterly Report, which we have prepared in accordance with U.S. GAAP. You should read the discussion and analysis together with such condensed consolidated interim financial statements and the related notes thereto.

Critical Accounting Estimates

Our condensed consolidated interim financial statements and the related notes thereto are prepared in accordance with U.S. GAAP. The preparation of condensed consolidated interim financial statements also requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenue, costs and expenses and related disclosures. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ significantly from our estimates. To the extent that there are differences between our estimates and actual results, our future financial statement presentation, financial condition, results of operations and cash flows will be affected.

---

There have been no material changes to our critical accounting estimates as described in our Annual Report on Form 10-K for the year ended December 31, 2023, which was filed with the SEC on March 28, 2024.

Recent Accounting Pronouncements

For a description of recent accounting pronouncements, including the expected dates of adoption and estimated effects, if any, on our condensed consolidated interim financial statements, please see Note 2, Significant accounting policies, in the Notes to the condensed consolidated interim financial statements of this Quarterly Report.

RESULT OF OPERATIONS

Revenue and Gross Profit

Our revenue is generated from product sales as well as development revenue. We recognize revenue when we satisfy performance obligations under the terms of our contracts, and control of our products is transferred to our customers in an amount that reflects the consideration we expect to receive from our customers in exchange for those products or services.

Product sales

Product sales include products, components, and samples sold to our customers. Revenue from the sale of prototypes and finished products is recognized at the point in time when control of the asset is transferred to the customer, generally on delivery of goods. We consider whether there are other obligations in the contract that are separate performance obligations to which a portion of the transaction price needs to be allocated. In determining the transaction price for the sale of prototypes, we consider the effects of variable consideration, the existence of significant financial components, non-cash consideration and consideration payable to the customer (if any).

Development revenue

Development revenue consists of revenues from contract services and research services, including non-recurring engineering services. Revenue from development activities is recognized over time, using an output method to measure progress towards complete satisfaction of the research activities and whether associated performance obligations identified within each contract have been satisfied.

Licensing revenue

Our licensing revenue is currently derived from per-unit royalty agreements. We record per unit royalty revenue in the same period in which the licensee’s underlying production occurs based on the usage or production reports obtained from the licensees. When such reports are not available during a given quarter within the time frame that allows us to adequately review the reports and include the actual amounts in the quarterly results for such quarter, we accrue the related revenue based on estimates of the licensees’ underlying production or usage.

Cost of sales

Cost of sales consists of direct material used in production, depreciation expenses of machinery and equipment used in production, salaries and benefits relating to the production staff, and other overhead costs allocated to production.

		Three months ended March 31,
		2024				2023				Change
		$				$				$				%
Product sales		$	85,169			$	58,699			$	26,470				45	%
Development revenue			3,141,759				1,257,479				1,884,280				150	%
Licensing revenue			45,329				96,081				(50,752	)			-53	%
Total Revenue			3,272,257				1,412,259				1,859,998				132	%
Cost of sales (exclusive of items shown separately below)			778,266				587,028				191,238				33	%
Depreciation and amortization included in cost of sales			3,673				10,047				(6,374	)			-63	%
Stock-based compensation included in cost of sales			(48,417	)			143,905				(192,322	)			-134	%
Gross profit		$	2,538,735			$	671,279			$	1,867,456				278	%
Gross profit percentage			78	%			48	%			30	%

Product Sales

Product sales for the three months ended March 31, 2024 is consistent with the same period of 2023.

Development Revenue

The increase in development revenue for the three months ended March 31, 2024 of $1.9 million is mainly due to the increase in our Lithography revenue. We derive a significant portion of our revenue from contract services with a confidential G10 central bank. In 2021, we acquired Nanotech which had a development contract for up to $41.5 million over a period of up to five years. These contract services incorporate both nano-optic and optical thin film technologies and are focused on developing authentication features for future banknotes.

---

Licensing revenue

The slight decrease in licensing revenue for the three months ended March 31,2024, compared to same period of 2023, was mainly due to a decrease in licensing revenue from a certain customer related to Nanotech.

Cost of sales

Cost of sales for the three months ended March 31, 2024 increased mainly due to an increase in material consumption.

Gross profit

The increase in gross profit for the three months ended March 31, 2024 of $1.9 million, compared to the same period of 2023, was mainly due to our increased revenue from contract services with a confidential G10 central bank during 2024.

Depreciation & amortization expense in Cost of sales

For the three months ended March 31, 2024, as compared to the same period of 2023, depreciation and amortization expense decreased by an insignificant amount.

Stock-based compensation expense in Cost of sales

For the three months ended March 31, 2024, as compared to the same period of 2023, stock-based compensation expense decreased by $0.2 million. The decrease was mainly due to a significant increase in forfeitures of equity-based awards in fiscal 2023 as a result of the Realignment and Consolidation Plan, and an increase in voluntary terminations.

Operating Expenses

		Three months ended March 31,
		2024				2023				Change
		$				$				$				%
Sales & marketing		$	332,964			$	2,307,353			$	(1,974,389	)			-86	%
General & administrative			3,926,643				6,769,437				(2,842,794	)			-42	%
Research & development			2,660,995				5,060,756				(2,399,761	)			-47	%
Depreciation & amortization expense			991,625				3,234,495				(2,242,870	)			-69	%
Stock-based compensation expense			310,825				1,858,440				(1,547,615	)			-83	%
Restructuring expense			266,035				—				266,035			*
Total operating expenses		$	8,489,087			$	19,230,481			$	(10,741,394	)			-56	%
* Not meaningful.

Sales & marketing

The decrease in selling & marketing expenses of $2.0 million for the three months ended March 31, 2024, as compared to the same period of 2023, is mainly due to a $1.0 million decrease in salaries and benefits due to decrease in headcount in the latter part of 2023 as a result of the Realignment and Consolidation Plan, a $0.4 million decrease in advertising and promotion costs including trade show and travel expenses, and a decrease of $0.6 million in consulting fees.

General & administrative

The decrease in general & administrative expenses of $2.8 million for the three months ended March 31, 2024, as compared to the same period of 2023, is mainly due to a $2.0 million decrease in salaries and benefits due to decrease in headcount in the latter part of 2023 as a result of the Realignment and Consolidation Plan, a $0.7 million reduction travel and other costs, a $0.2 million reduction in IT & software costs, a $0.2 million decrease in stock exchange fee, a $0.1 million reduction in insurance cost, and partially offset by a $0.4 million increase in professional cost.

Research & development

The decrease research & development expenses of $2.4 million for the three months ended March 31, 2024, as compared to the same period of 2023, is mainly due to a $1.3 million decrease in salaries and benefits due to decrease in headcount in the latter part of 2023 as a result of the Realignment and Consolidation Plan, a $0.9 million decrease in R&D materials and patent fees, and a $0.1 million decrease in travel, subscription and other expenses.

Depreciation & amortization expense in Operating expenses

For the three months ended March 31, 2024, as compared to the same period of 2023, depreciation amortization expense reduced by $2.2 million. The decrease in the three months ended March 31, 2024, compared to the same period ended March 31, 2023, was primarily due to an impairment of long-lived assets recorded in the fourth quarter ended December 31, 2023.

---

Stock-based compensation expense in Operating expenses

For the three months ended March 31, 2024, as compared to the same period of 2023, stock-based compensation expenses decreased by $1.5 million, mainly due to a significant increase in forfeitures of equity-based awards in fiscal 2023 and the first quarter ended March 31, 2024 as a result of the Realignment and Consolidation Plan and an increase in voluntary terminations.

Restructuring expense

For the three months ended March 31, 2024, we recorded $0.3 million of restructuring expenses in relation to the 2023 Realignment and Consolidation Plan. There were no such expenses during the same period of 2023.

Other Expenses, net

		Three months ended March 31,
		2024				2023				Change
		$				$				$				%
Interest expense, net		$	(108,766	)		$	(112,998	)		$	4,232				-4	%
Realized gain (loss) on foreign exchange, net			62,445				(40,689	)			103,134				-253	%
Unrealized gain (loss) on foreign exchange, net			(1,513,055	)			325,600				(1,838,655	)			-565	%
Other income (expenses), net			1,314				(578,120	)			579,434				-100	%
Total other expense, net		$	(1,558,062	)		$	(406,207	)		$	(1,151,855	)			284	%

Interest expense, net

The net interest expense for the quarter ending March 31, 2024, was largely comparable to that of the same period in 2023.

Realized gain (loss) on foreign exchange, net

For the three months ended March 31, 2024 as compared to the same period of 2023, the increase in net realized gain on foreign exchange was primarily driven by transaction gains in intercompany transfer to Canadian subsidiaries. Canadian dollar depreciated against the US dollar during the first quarter ended March 31, 2024.

Unrealized gain (loss) on foreign exchange, net

The shift from the net unrealized gain on foreign exchange in the three months ended March 31, 2023 to the net unrealized foreign exchange loss in the three months ended March 31, 2024 was primarily attributable to the revaluation of intercompany balances whereas unrealized loss was increased primarily due to the Canadian dollar's depreciation against the US dollar.

Other income (expense), net

The shift from the other expense, net, for the three months ended March 31, 2023 to the other income, net, for the three months ended March 31, 2024, was primarily due to a net expense of $0.6 million related to the notes receivable from Next Bridge. During the three months ended March 31, 2023, we recorded a $1.0 million of credit loss provision expense for the notes receivable from Next Bridge in accordance with ASC 326. This was partially offset by a $0.4 million in interest income accrued on the Next Bridge notes receivable. We sold the Next Bridge notes receivable in August 2023.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity risk is the risk that we will not meet our financial obligations as they become due after use of currently available cash. We have a planning and budgeting process to monitor operating cash requirements, including amounts projected for capital expenditures, which are adjusted as input variables change. These variables include, but are not limited to, our ability to generate revenue from current and prospective customers, general and administrative requirements and the availability of equity or debt capital and government funding. As these variables change, we currently will be required to issue equity or obtain debt financing.

On March 31, 2024, we had cash and cash equivalents of approximately $7.0 million including $0.6 million in restricted cash compared to $10.3 million in cash and cash equivalents at December 31, 2023, including $0.6 million in restricted cash.

During the three months ended March 31, 2024, our principal sources of liquidity included a $3.3 million of revenue, $3.0 million of net proceeds obtained through the issuance of common stock and warrants under the February 2024 Offering, and $0.7 million receipt from Mr. McCabe in relation to the Release Agreement with Mr. McCabe.

Our primary uses of liquidity included $3.9 million in salaries, $2.3 million in professional fees and stock exchange fees, $1.3 million changes in working capital, $0.7 million in rent and utilities, $0.4 million in insurance, $0.3 million in restructuring expenses, $0.2 million in R&D materials and patents fees, $0.1 million in travel, advertisement and other costs and $0.1 million in capital expenditures.

On February 21, 2024, we completed a registered direct offering, which included (i) 600,000 shares of common stock, (ii) Pre-funded Warrants for up to 250,000 shares of common stock, and (iii) warrants to purchase up to a total of 850,000 shares of common stock.

---

Through this offering, we secured net proceeds of approximately $3.0 million, after accounting for placement agent fees and other estimated expenses associated with the offering.

On May 2, 2024, our board of directors approved a reduction in our workforce by approximately 80% of our employees in order to preserve cash resources.

We will require additional funding to continue as a going concern and are dependent on raising capital to expand the commercialization of our products, fund our operations and further our research and development activities and ultimately attain profitable operations. Future capital requirements may vary materially from period to period and will depend on many factors, including the timing and extent of spending on research and development efforts and the ongoing investments to support the growth of our business.

Going Concern

In accordance with ASC 205-40, Going Concern, we evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the condensed consolidated interim financial statements included in this Quarterly Report are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the condensed consolidated interim financial statements are issued. When substantial doubt exists under this methodology, we evaluate whether the mitigating effect of our plans sufficiently alleviates substantial doubt about our ability to continue as a going concern. The mitigating effect of our plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the condensed consolidated interim financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about our ability to continue as a going concern within one year after the date that the condensed consolidated interim financial statements are issued. In performing its analysis, we excluded certain elements of our operating plan that cannot be considered probable. Under ASC 205-40, the receipt of potential funding from future partnerships, equity or debt issuances, potential achievement of milestones from customer agreements and reductions in workforce cannot be considered probable at this time because these plans are not entirely within our control and/or have not been approved by our board of directors as of the date of issuance of the condensed consolidated interim financial statements.

Our expectation to generate operating losses and negative operating cash flows in the future and the need for additional funding to support our planned operations raise substantial doubt regarding our ability to continue as a going concern. Our plans to alleviate the conditions that raise substantial doubt include reduced spending, and the pursuit of additional capital. We have concluded the likelihood that our plan to successfully obtain sufficient funding from one or more of these sources, or adequately reduce expenditures, while possible, is less than probable. Accordingly, we have concluded that substantial doubt exists about our ability to continue as a going concern for a period of at least 12 months from the date of issuance of the condensed consolidated interim financial statements. See Note 3, Going Concern, in the Notes to the condensed consolidated interim financial statements of this Quarterly Report for further information.

The accompanying financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above.

The following table summarizes our cash flows for the periods presented:

		Three months ended March 31,
		2024				2023
Net cash used in operating activities		$	(5,922,764	)		$	(15,520,162	)
Net cash provided by (used in) investing activities			32,096				(437,528	)
Net cash provided by financing activities			2,652,704				10,664,073
Net decrease in cash, cash equivalents and restricted cash		$	(3,237,964	)		$	(5,293,617	)

Net cash used in operating activities

During the three months ended March 31, 2024, net cash used in operating activities of $5.9 million was primarily driven by a net loss of $7.5 million for the period, and non-cash adjustments of $2.9 million mainly due to unrealized foreign currency exchange loss of $1.5 million, depreciation and amortization of $1.0 million, non-cash lease expense of $0.3 million, stock-based compensation of $0.3 million, which was partially offset by a $0.4 million decrease related to a change in deferred revenue. In addition, there was $1.3 million cash used by working capital primarily due to a $3.6 million decrease in trade payables, accruals and other accruals, a $0.4 million decrease in restructuring costs accrual, a $0.4 million decrease in accounts receivables and other receivables, a $0.4 million decrease in operating lease liabilities, which was partially offset by a $3.5 million increase related to prepaid expenses and other current assets.

During the three months ended March 31, 2023, net cash used in operating activities of $15.5 million was primarily driven by a net loss of $18.7 million for the period, and non-cash adjustments of $5.9 million mainly due to depreciation and amortization of $3.2 million, stock-based compensation of $2.0 million, and credit loss expenses of $1.0 million. In addition, there was $2.7 million cash used by

---

working capital primarily due to a $1.7 million decrease in trade payables, accruals and other accruals as well as a $0.8 million increase in prepaid expenses and other current assets.

Net cash provided by (used in) investing activities

During the three months ending March 31, 2024, we experienced an immaterial net cash inflow from investing activities. This was primarily due to a $0.1 million disbursement from an interest-free loan from EDC, substantially offset by $0.1 million in capital expenditures related to the construction of the Highfield Park Facility in Nova Scotia, Canada.

During the three months ended March 31, 2023, net cash used in investing activities of $0.4 million was primarily driven by $1.7 million of capital expenditure associated with the construction of the Highfield Park Facility in Nova Scotia, Canada as well as the Thurso facility expansion in Quebec, offset by $1.0 million proceeds from collection of notes receivable and $0.3 million proceeds from government loan.

Net cash provided by financing activities

During the three months ended March 31, 2024, net cash provided by financing activities of $2.7 million was primarily driven by the $3.0 million net proceeds obtained through the issuance of common stock and warrants in the February 2024 Offering, partially offset by a repayment of $0.4 million in interest-free government loans.

During the three months ended March 31, 2023, net cash provided by financing activities of $10.7 million was primarily driven by the $10.0 million net proceeds obtained through the issuance of common stock under the At-the-Market Equity Offering Program in addition to $0.7 million proceeds from stock options exercise.

Commitments and contractual obligations

For a description of our commitments and contractual obligations, please see Note 19, Commitments and contingencies, in the Notes to the condensed consolidated interim financial statements of this Quarterly Report.

Off-Balance Sheet Arrangements

Off-balance sheet firm commitments relating to an outstanding letter of credit amounted to approximately $0.5 million as of December 31, 2023, which is secured by restricted cash. Please see Note 19, Commitments and Contingencies, in the notes to the unaudited condensed consolidated interim financial statements of this Quarterly Report. We do not maintain any other off-balance sheet arrangements.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

This item is not required for a smaller reporting company.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our periodic reports filed with the SEC is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow for timely decisions regarding required disclosure.

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of March 31, 2024.

Although management believes there has been significant improvement in the design and implementation of our internal controls over financial reporting during the first three months of 2024, we still consider there to be a material weakness in our internal control over financial reporting that has not yet been remediated as previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023. Accordingly, our management, with the participation of our principal executive officer and principal financial officer, concluded that our disclosure controls and procedures were not effective as of March 31, 2024.

Nevertheless, giving full consideration to the material weakness and the progress made in addressing them since December 31, 2023, we have concluded that the condensed consolidated interim financial statements included in this Quarterly Report present fairly, in all material respects, our financial position, the results of our operations and our cash flows for each of the periods presented in conformity with U.S. GAAP.

---

Remediation of Previously Reported Material Weakness

Management has implemented a number of measures to address the material weakness disclosed in the Form 10-K for the year ended December 31, 2023. These measures aim to further enhance our internal controls over financial reporting to ensure that management can routinely prepare our financial statements under U.S. GAAP and remain in compliance with the SEC reporting requirements.

To remediate the weakness described above, we have performed the following:

To remediate the weakness described above, we are in process of implementing the following:

Changes in Internal Controls

Except for the remediation activities described above, there were no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) that occurred during the three months ended March 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Limitations on Effectiveness of Internal Controls

Our management, including our principal executive officer and principal financial officer, does not expect that disclosure controls or internal controls, when effective, will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. In addition, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty, and that breakdowns can occur because of simple errors or mistake.

Additionally, controls can be circumvented by the individual acts of some persons, by collusion of two or more people or by management’s override of the control. The design of any systems of controls is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving our stated goals under all potential future conditions. Over time, control may become inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because of these inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected. Individual persons may perform multiple tasks which normally would be allocated to separate persons and therefore extra diligence must be exercised during the period these tasks are combined.

---

PART II—OTHER INFORMATION

Item 1. Legal Proceedings

From time to time, we are subject to threats of litigation or actual litigation in the ordinary course of business, some of which may be material. Other than as disclosed in Note 19, Commitments and contingencies, in the notes to the condensed consolidated interim financial statements of this Quarterly Report, we are not currently a party to any pending legal proceedings that, if determined adversely to us, would, in our opinion, have a material effect on our financial position, results of operations, or cash flows or that would not be covered by our existing liability insurance. The results of any litigation cannot be predicted with certainty, and regardless of the outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.

Item 1A. Risk Factors

There have been no material changes from the risk factors previously disclosed under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, except the following:

Our ability to secure financing is limited by insufficient authorized shares of common stock, potentially impacting our ongoing operations.

Since inception, our cash requirements have been met primarily through the proceeds from the sale of our securities. As of the date of this Quarterly Report, we have issued substantially all of our unreserved authorized shares of common stock. Our stockholders did not approve the proposal to increase the number of authorized shares at the Special Meeting of Stockholders held on April 15, 2024. As of the date of this Quarterly Report, we have not scheduled another special meeting of stockholders. Currently, we do not have enough authorized and unreserved shares of common stock available, which could adversely impact our ability to pursue opportunities that may involve issuing shares. This limitation could affect the board's ability to make decisions that would be in the best interests of the Company and our shareholders, including securing financing and strategic transactions. Failure to obtain financing through the issuance of our securities, including our common stock, may cause us to be unable to continue our operations or execute our business plans.

We may encounter operational disruptions due to delays or failures in paying our suppliers.

Our business operations depend significantly on the timely supply of essential services and materials from our key suppliers. A shortage of cash flow or insufficient liquidity could impair our ability to make timely payments to these suppliers. If we are unable to maintain satisfactory relationships with our suppliers due to non-payment or delayed payment, they may alter their terms of sales to us, require advance payments, or discontinue their supplies, any of which could disrupt our operations. Such disruptions could lead to delays in production and delivery of our products, impacting our revenue and harming our business reputation and adversely affect our financial position or results of operations.

We continue to evaluate strategic alternatives due to our cash runway and there can be no assurance that any strategic alternative will be successful.

As of March 31, 2024, we had cash and cash equivalents of approximately $7.0 million. Management has determined that there is substantial doubt about the Company's ability to continue as a going concern. We have not yet generated significant revenue from operations and do not anticipate that we will generate sufficient revenue from operations in the near term to sustain our operations and therefore we will need to raise capital to sustain our operations. In connection therewith, on May 2, 2024, our board of directors approved a reduction in our workforce by approximately 80% of our employees in order to preserve cash resources.

We continue to evaluate all available strategic alternatives including, but not limited to, the divestiture of assets, additional financing security and/or the sale of the Company. There can be no assurance regarding the outcome of this process. Without an influx of cash to support operations, we face:

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None.

Item 3. Defaults Upon Senior Securities

None.

---

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

During the three months ended March 31, 2024, no director or officer of the Company adopted, modified or terminated a "Rule 10b5-1 trading arrangement" or "non-Rule 10b5-1 trading arrangement" as each term is defined in Item 408 of Regulation S-K.

---

Item 6. Exhibits

Furnish the exhibits required by Item 601 of Regulation S-K (§ 229.601 of this chapter).

				Incorporated by Reference
Exhibit Number		Exhibit Description		Form		Exhibit Number		Filing Date		Filed Herewith
3.1.0		Articles of Incorporation		10-K		3.1		18-Mar-19
3.1.1		Certificate of Amendment to Articles of Incorporation dated December 10, 2014		10-Q		3.2		15-May-15
3.1.2		Certificate of Amendment to Articles of Incorporation dated September 15, 2015		10-Q		3.3		12-Nov-15
3.1.3		Certificate of Amendment to Articles of Incorporation dated August 18, 2017.		10-Q		3.4		9-Nov-18
3.1.4		Amendment to the Articles of Incorporation of Torchlight Energy Resources, Inc., dated June 14, 2021		8-K		3.1		16-Jun-21
3.1.5		Certificate of Amendment related to the Reverse Stock Split and Name Change, filed June 25, 2021		8-K		3.1		29-Jun-21
3.1.6		Certificate of Change related to Reverse Stock Split, filed on January 26, 2024		8-K		3.2		29-Jan-24
3.2.0		Certificate of Designation of Preferences, Rights and Limitations of Series B Special Voting Preferred Stock, dated June 14, 2021		8-K		3.3		16-Jun-21
3.3.0		Certificate of Withdrawal of Certificate of Designation of Preference, Rights, and Limitations of Series A Non-Voting Preferred Stock		8-K		3.3.2		15-Dec-22
3.4.0		Certificate of Designated of Series C Preferred stock, filed on January 26,2024.		8-K		3.3		29-Jan-24
3.5.0		Amended and Restated Bylaws		8-K		3.1		26-Oct-16
3.5.1		First Amendment to Amended and Restated Bylaws of Meta Materials Inc.		8-K		3.1		20-Oct-23
4.1.0		Form of Pre-Funded Warrant (issued in February 2024)		8-K		4.1		21-Feb-24
4.2.0		Form of Warrant (issued in February 2024)		8-K		4.2		21-Feb-24
4.3.0		Form of Letter Agreement (entered in February 2024)		8-K		4.3		21-Feb-24
10.1.0		Form of Securities Purchase Agreement		8-K		10.1		21-Feb-24
31.1		Certification Pursuant to Rules 13a-14(a) and 15d-14(a) as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002								X
32.1		Certification Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.								X
101.INS		Inline XBRL Instance Document–the instance document does not appear in the Interactive Data File as its XBRL tags are embedded within the Inline XBRL document								X
101.SCH		Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents								X
104		Cover page formatted as Inline XBRL and contained in Exhibit 101								X

 

+	Indicates management contract or compensatory plan.

 

---

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Meta Materials Inc.
Dated: May 13, 2024		By:	/s/ Uzi Sasson
			Uzi Sasson
			President and Chief Executive Officer
			(Principal Executive Officer and Principal Financial Officer)

 

---

Exhibit 31.1

CERTIFICATION PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Uzi Sasson, certify that:

 

 

Date: May 13, 2024			By:		/s/ Uzi Sasson
					Uzi Sasson
					President and Chief Executive Officer
					(Principal Executive Officer and Principal Financial Officer)

 

---

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, I, Uzi Sasson, the Chief Executive Officer of Meta Materials Inc. (the “Company”), hereby certify, that, to my knowledge:

 

 

Date: May 13, 2024			By:		/s/ Uzi Sasson
					Uzi Sasson
					President and Chief Executive Officer
					(Principal Executive Officer and Principal Financial Officer)

 

---

v3.24.1.1.u2

Cover Page - shares	3 Months Ended
	Mar. 31, 2024	May 10, 2024
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Entity Registrant Name	Meta Materials Inc.
Entity Central Index Key	0001431959
Entity File Number	001-36247
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Interactive Data Current	Yes
Entity Shell Company	false
Entity Small Business	true
Entity Emerging Growth Company	false
Document Quarterly Report	true
Document Transition Report	false
Entity Tax Identification Number	74-3237581
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	60 Highfield Park Drive
Entity Address, City or Town	Dartmouth
Entity Address, State or Province	NS
Entity Address, Country	CA
Entity Address, Postal Zip Code	B3A 4R9
City Area Code	902
Local Phone Number	482-5729
Entity Common Stock, Shares Outstanding		6,695,536
Title of 12(b) Security	Common Stock, par value $0.001 per share
Trading Symbol	MMAT
Security Exchange Name	NASDAQ

v3.24.1.1.u2

Condensed Consolidated Interim Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 6,395,929	$ 9,723,690
Restricted Cash	564,576	578,406
Accounts receivables	2,048,426	942,793
Subscription receivables		881,100
Inventory	123,877	168,747
Prepaid expenses and other current assets	1,587,492	5,071,363
Due from related parties		29,906
Total current assets	10,720,300	17,396,005
Intangible assets, net	16,936,346	18,030,301
Property, plant and equipment, net	17,848,873	18,601,614
Operating lease right-of-use ("ROU") assets	855,641	1,200,417
Total assets	46,361,160	55,228,337
Current liabilities
Trade payables	9,696,923	10,270,386
Accruals and other payables	3,841,799	7,249,291
Restructuring costs accrual	1,008,924	1,182,112
Current portion of long-term debt	545,215	801,628
Current portion of deferred revenues	665,955	1,054,557
Current portion of deferred government assistance	566,647	590,954
Current portion of funding obligation	959,410	982,912
Current portion of operating lease liabilities	1,296,404	1,452,863
Total current liabilities	18,581,277	23,584,703
Deferred revenues	384,876	419,035
Deferred government assistance	428,861	391,148
Long-term operating lease liabilities	5,671,681	5,973,657
Long-term debt	2,959,082	2,922,989
Total liabilities	28,025,777	33,291,532
Commitments and contingencies (Note 19)
Stockholders' equity
Common stock - $0.001 par value; 10,000,000 shares authorized, 6,694,635 shares issued and outstanding at March 31, 2024, and $0.001 par value; 10,000,000 shares authorized, 5,659,438 shares issued and outstanding at December 31, 2023	6,694	543,046
Treasury stock, at cost, 18,536 shares at March 31, 2024 and 0 shares at December 31, 2023	(123,859)
Additional paid-in capital	639,618,677	635,860,437
Accumulated other comprehensive loss	(4,646,182)	(5,455,145)
Accumulated deficit	(616,519,947)	(609,011,533)
Total stockholders' equity	18,335,383	21,936,805
Total liabilities and stockholders' equity	$ 46,361,160	$ 55,228,337

v3.24.1.1.u2

Condensed Consolidated Interim Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Common Stock, Par or Stated Value Per Share	$ 0.001	$ 0.001
Common Stock, Shares Authorized	10,000,000	10,000,000
Common Stock, Shares, Issued	6,694,635	5,659,438
Common Stock, Shares, Outstanding	6,694,635	5,659,438
Treasury Stock Common Shares	18,536	0

v3.24.1.1.u2

Condensed Consolidated Interim Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenue	$ 3,272,257	$ 1,412,259
Cost of sales (exclusive of items shown separately below)	778,266	587,028
Depreciation and amortization expense included in cost of sales	3,673	10,047
Stock-based compensation expense (recovery) included in cost of sales	(48,417)	143,905
Gross profit	2,538,735	671,279
Operating Expenses:
Selling & marketing	332,964	2,307,353
General & administrative	3,926,643	6,769,437
Research & development	2,660,995	5,060,756
Depreciation & amortization expenses	991,625	3,234,495
Stock-based compensation expense	310,825	1,858,440
Restructuring expense	266,035
Total operating expenses	8,489,087	19,230,481
Loss from operations	(5,950,352)	(18,559,202)
Interest expense, net	(108,766)	(112,998)
Realized gain (loss) on foreign exchange, net	62,445	(40,689)
Unrealized gain (loss) on foreign exchange, net	(1,513,055)	325,600
Other income (expenses), net	1,314	(578,120)
Total other expenses, net	(1,558,062)	(406,207)
Loss before income taxes	(7,508,414)	(18,965,409)
Income tax recovery		296,731
Net loss	(7,508,414)	(18,668,678)
Other comprehensive loss, net of tax
Unrealized foreign currency translation gain	808,963	322,787
Total other comprehensive income	808,963	322,787
Comprehensive loss	$ (6,699,451)	$ (18,345,891)
Basic loss per share	$ (1.21)	$ (5.06)
Diluted loss per share	$ (1.21)	$ (5.06)
Weighted average number of shares outstanding - basic	6,180,363	3,688,793
Weighted average number of shares outstanding - diluted	6,180,363	3,688,793
Product sales [Member]
Revenue:
Total revenue	$ 85,169	$ 58,699
Development revenue [Member]
Revenue:
Total revenue	3,141,759	1,257,479
Licensing revenue [Member]
Revenue:
Total revenue	$ 45,329	$ 96,081

v3.24.1.1.u2

Condensed Consolidated Interim Statements of Changes in Stockholders' Equity - USD ($)	Total	Common Stock [Member]	Treasury [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2022	$ 378,564,153	$ 340,425		$ 590,962,866	$ (5,242,810)	$ (207,496,328)
Beginning balance, shares at Dec. 31, 2022		3,622,479
Net loss	(18,668,678)					(18,668,678)
Other comprehensive income	322,787				322,787
Issuance of common stock	10,477,069	$ 17,574		10,459,495
Issuance of common stock, Shares		175,740
Stock issuance costs	(438,785)			(438,785)
Exercise of stock options	711,246	$ 2,634		708,612
Exercise of stock options , Shares		26,342
Settlement of restricted stock units		$ 1,289		(1,289)
Settlement of restricted stock units, Shares		12,888
Stock-based compensation	2,002,340			2,002,340
Ending balance at Mar. 31, 2023	372,970,132	$ 361,922		603,693,239	(4,920,023)	(226,165,006)
Ending balance, shares at Mar. 31, 2023		3,837,449
Beginning balance at Dec. 31, 2022	378,564,153	$ 340,425		590,962,866	(5,242,810)	(207,496,328)
Beginning balance, shares at Dec. 31, 2022		3,622,479
Net loss	(398,200,000)
Ending balance at Dec. 31, 2023	21,936,805	$ 543,046		635,860,437	(5,455,145)	(609,011,533)
Ending balance, shares at Dec. 31, 2023		5,659,438
Reverse stock split fractional shares adjustment		$ (537,210)		537,210
Reverse stock split fractional shares adjustment, Shares		177,686
Net loss	(7,508,414)					(7,508,414)
Other comprehensive income	808,963				808,963
Issuance of common stock and warrants	3,433,750	$ 600		3,433,150
Issuance of common stock and warrants, Shares		600,000
Stock issuance costs	(659,851)			(659,851)
Exercise of warrants	250	$ 250
Exercise of warrants, Shares		250,000
Settlement of restricted stock units	(164)	$ 8	$ (164)	(8)
Settlement of restricted stock units, Shares		7,511	(19)
Stock-based compensation	262,408			262,408
Fair value adjustments of June 2022 Warrants and December 2023 Warrants	185,331			185,331
Shares originally purchased by Mr. McCabe which were reassigned to META upon termination of SPA	$ (123,695)		$ (123,695)
Shares originally purchased by Mr. McCabe which were reassigned to META upon termination of SPA, Shares	(18,517)		(18,517)
Ending balance at Mar. 31, 2024	$ 18,335,383	$ 6,694	$ (123,859)	$ 639,618,677	$ (4,646,182)	$ (616,519,947)
Ending balance, shares at Mar. 31, 2024		6,694,635	(18,536)

v3.24.1.1.u2

Condensed Consolidated Interim Statements of Changes in Stockholders' Equity (Parenthetical)	3 Months Ended
	Mar. 31, 2024 shares
Statement of Stockholders' Equity [Abstract]
Shares acquired	18,517

v3.24.1.1.u2

Condensed Consolidated Interim Statements of Cash Flows - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Cash flows from operating activities:
Net loss	$ (7,508,414)	$ (18,668,678)	$ (398,200,000)
Adjustments to reconcile net loss to net cash used in operating activities:
Non-cash interest expense	119,985	137,657
Non-cash interest income		(391,111)
Non- cash lease expense	303,336	401,528
Deferred income tax		(296,731)
Depreciation and amortization expense	995,298	3,244,511
Credit loss expense		981,861
Unrealized foreign currency exchange (gain) loss	1,520,386	(221,535)
Change in deferred revenue	(399,220)	(4,580)
Stock-based compensation and other non-cash personnel expense	262,408	2,002,343
Others	57,406	18,843
Changes in operating assets and liabilities	(1,273,949)	(2,724,270)
Net cash used in operating activities	(5,922,764)	(15,520,162)	(42,200,000)
Cash flows from investing activities:
Purchases of property, plant and equipment	(115,995)	(1,693,768)
Proceeds from below-market capital government loan	148,091	256,240
Proceeds from collection of Next Bridge Notes Receivable		1,000,000
Net cash provided by (used in) investing activities	32,096	(437,528)
Cash flows from financing activities
Proceeds from issuance of common stock and warrants	3,433,750	10,477,069
Stock issuance costs paid on the issuance of common stock and warrants	(418,372)	(438,785)
Repayments of long-term debt	(362,760)	(85,457)
Proceeds from stock option and warrants exercises	250	711,246
Repurchases of common stock for income tax withheld upon settlement of restricted stock units	(164)
Net cash provided by financing activities	2,652,704	10,664,073
Net decrease in cash, cash equivalents and restricted cash	(3,237,964)	(5,293,617)
Cash, cash equivalents and restricted cash at beginning of the year	10,302,096	11,811,471	11,811,471
Effects of exchange rate changes on cash, cash equivalents and restricted cash	(103,627)	23,769
Cash, cash equivalents and restricted cash at end of the period	6,960,505	6,541,623	$ 10,302,096
Supplemental cash flow information
Accrued purchases of property, equipment and patents	16,689	$ 1,998,469
ROU assets derecognized from termination of operating lease obligations	250,878
Common stock issuance costs in accrued liabilities or accounts payable	56,150
Non-cash issuance costs as a result of amendment of June 2022 Warrants and December 2023 Warrants	185,331
18,517 shares originally purchased by Mr. McCabe which were reassigned to META upon termination of SPA	$ 123,695

v3.24.1.1.u2

Condensed Consolidated Interim Statements of Cash Flows (Parenthetical)	3 Months Ended
	Mar. 31, 2024 shares
Statement of Cash Flows [Abstract]
Shares repurchased	18,517

v3.24.1.1.u2

Pay vs Performance Disclosure - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (7,508,414)	$ (18,668,678)	$ (398,200,000)

v3.24.1.1.u2

Insider Trading Arrangements	3 Months Ended
	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false
Rule 10b5-1 Arrangement Modified	false
Non-Rule 10b5-1 Arrangement Modified	false

v3.24.1.1.u2

Corporate Information	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Corporate Information	1. Corporate Information Meta Materials Inc. (also referred to herein as the “Company”, “META”, “we”, “us”, or “our”) is an advanced materials and nanotechnology company. We are developing materials that we believe can improve the performance and efficiency of many current products as well as allow new products to be developed that cannot otherwise be developed without such materials. We believe we are positioned for growth, by pioneering a new category of intelligent surfaces, which will allow us to become a metamaterials industry leader. We enable our potential customers across a range of industries - consumer electronics, 5G communications, healthcare, aerospace, automotive, and clean energy - to deliver improved products to their customers. For example, our nano-optic metamaterial technology is being used to develop anti-counterfeiting security features for a Central Bank customer and for currencies and authentication for global brands. We currently have over 455 active patent documents, of which 346 patents have issued. Our principal executive office is located at 60 Highfield Park Drive, Dartmouth, Nova Scotia, Canada.

v3.24.1.1.u2

Significant Accounting Policies	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Significant Accounting Policies	2. Significant Accounting Policies Basis of presentation These unaudited condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP. Our fiscal year-end is December 31. The unaudited condensed consolidated interim financial statements include the accounts of Meta Materials Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated on consolidation. These unaudited condensed consolidated interim financial statements do not include all of the information and notes required by U.S. GAAP for annual financial statements. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements and notes for the years ended December 31, 2023 and 2022, filed with the SEC. Reverse Stock Split On January 26, 2024, we filed a Certificate of Change with the Nevada Secretary of State to effect a reverse stock split of our common stock at a rate of 1-for-100 (the "Reverse Stock Split"), which became effective as of January 29, 2024 (the "Effective Date"). The Reverse Stock Split was approved by the board of directors in accordance with Nevada law. The Reverse Stock Split did not have any impact on the par value of common stock. On the Effective Date, every one hundred shares of Common Stock issued and outstanding were automatically combined into one share of Common Stock, without any change in the par value per share. As the per-share par value did not change, we reclassified $0.5 million from Common Stock to Additional Paid-in-Capital on the Effective Date. The exercise prices and the number of shares issuable upon exercise of outstanding stock options, equity awards and warrants, and the number of shares available for future issuance under the equity incentive plans were adjusted in accordance with their respective terms. The Reverse Stock Split affected all stockholders uniformly and did not alter any stockholder’s percentage interest in our Common Stock. We did not issue any fractional shares in connection with the Reverse Stock Split. Instead, fractional shares were rounded up to the next largest whole number, resulting in the issuance of 177,686 shares upon the Effective Date. The Reverse Stock Split did not modify the relative rights or preferences of the Common Stock. Unless otherwise indicated, all issued and outstanding shares of common stock and all outstanding securities entitling their holders to purchase shares of our common stock or acquire shares of our common stock, including stock options, restricted stock units, and warrants per share data, share prices and exercise prices, as required by the terms of those securities, have been adjusted retroactively to reflect the Reverse Stock Split. The following table provides details on how the Reverse Stock Split affects our outstanding common stock and the calculation of Earnings Per Share:     As of March 31, 2023       Post-Reverse Stock Split     Pre-Reverse Stock Split    Number of shares authorized     10,000,000       1,000,000,000    Number of shares issues and outstanding     3,837,449       383,744,889    Weighted average number of shares outstanding - basic and diluted     3,688,793       368,879,341               Three months ended       March 31, 2023     Post-Reverse Stock Split     Pre-Reverse Stock Split    Basic and diluted loss per share   $ (5.06 )   $ (0.05 ) Reclassification – Certain prior year amounts have been reclassified in the accompanying unaudited condensed consolidated interim financial statements to conform to the current period presentation: • Licensing revenue is reported in a separate line under Revenue in the accompanying unaudited condensed statements of operations and comprehensive loss. Previously, Licensing revenue was reported as part of Development revenue. Amounts related to Licensing revenue for the three months ended March 31, 2023 have been separately presented throughout this Quarterly Report to reflect this reclassification of Licensing revenue to conform to the current period presentation. There are no changes in total Revenue and Gross profit. • Depreciation and amortization expenses and stock-based compensation expense are reported in a separate line under Cost of sales and Operating expenses in the accompanying unaudited condensed consolidated interim statements of operations and comprehensive loss. Previously, those expenses were reported as a same line item under Cost of sales, Sales & marketing, General & administrative and Research & development. Amounts related to depreciation and amortization expenses and stock-based compensation expense for the three months ended March 31, 2023 have been separately presented throughout this Quarterly Report to reflect this reclassification of depreciation and amortization expenses and stock-based compensation expense to conform to the current period presentation. There are no changes in total Cost of sales, Gross profit and Operating expenses. • Realized gain (loss) on foreign exchange, net and Unrealized gain (loss) on foreign exchange, net are reported in a separate line under Other income (expense), net in the accompanying unaudited condensed consolidated interim statements of operations and comprehensive loss. Previously, those expenses were reported as a single line, Gain (loss) on foreign exchange, net, under Other income (expense), net in the unaudited condensed consolidated interim statements of operations and comprehensive loss. Amounts related to Gain (loss) on foreign exchange, net, for the three months ended March 31, 2023 have been separately presented throughout this Quarterly Report to reflect this reclassification of Realized gain (loss) on foreign exchange, net and Unrealized gain (loss) on foreign exchange to conform to the current period presentation. There are no changes in total Other income (expense), net. Recently Adopted Accounting Pronouncements As of March 31, 2024 and for the period then ended, there were no recently adopted accounting standards that had a material impact on our consolidated financial statements. Accounting Pronouncements Not Yet Adopted ASU 2023-07 In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in Accounting Standards Codification ("ASC") 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07. ASU 2023-09 In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We do not anticipate the adoption of this standard will have a material effect on our consolidated financial statements and related disclosures.

v3.24.1.1.u2

Going Concern	3 Months Ended
	Mar. 31, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	3. Going Concern At each reporting period, we evaluate whether there are conditions or events that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued. Our evaluation entails analyzing prospective operating budgets and forecasts for expectations of our cash needs and comparing those needs to the current cash and cash equivalent balances. We are required to make certain additional disclosures if we conclude substantial doubt about our ability to continue as a going concern exists and it is not alleviated by our plans or when our plans alleviate substantial doubt about our ability to continue as a going concern. In accordance with Accounting Standards Codification, or ASC, 205-40, Going Concern, we evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that these condensed consolidated interim financial statements are issued. This evaluation initially does not take into consideration the potential mitigating effect of management’s plans that have not been fully implemented as of the date the financial statements are issued. When substantial doubt exists under this methodology, management evaluates whether the mitigating effect of our plans sufficiently alleviates substantial doubt about our ability to continue as a going concern. The mitigating effect of management’s plans, however, is only considered if both (1) it is probable that the plans will be effectively implemented within one year after the date that the condensed consolidated interim financial statements are issued, and (2) it is probable that the plans, when implemented, will mitigate the relevant conditions or events that raise substantial doubt about the entity’s ability to continue as a going concern within one year after the date that these condensed consolidated interim financial statements are issued. In performing its analysis, management excluded certain elements of its operating plan that cannot be considered probable. We have incurred net losses of $7.5 million and $398.2 million for the three months ended March 31, 2024 and the twelve months ended December 31, 2023, respectively, and have an accumulated deficit of $616.5 million as of March 31, 2024. As of March 31, 2024, we had a working capital deficit of $7.9 million (As of December 31, 2023 – working capital deficit of $6.2 million). In addition, we have incurred negative cash flows from operating activities of $5.9 million and $42.2 million for the three months ended March 31, 2024 and the twelve months ended December 31, 2023, respectively. Additionally, we did not receive stockholder approval to increase the number of common stock authorized and available for issuance during the Special Meeting of Stockholders held on April 15, 2024. As a result, we do not have a sufficient number of authorized, available and unreserved common stock for issuance, to raise additional funds through equity financing. Our expectation of incurring operating losses and negative operating cash flows in the future, the need for additional funding to support our planned operations, and the risk that we may not receive approval to increase the number of common stock authorized and available for issuance raise substantial doubt regarding our ability to continue as a going concern for a period of one year after the date that these condensed consolidated interim financial statements are issued. Management's plans to alleviate the events and conditions that raise substantial doubt include reduced spending, the pursuit of additional financing, and other measures to increase cash inflows. On June 6, 2023, our board of directors approved a revised operating plan (the "Realignment and Consolidation Plan") pursuant to a process for increased focus on key applications with the greatest near-term revenue potential, and of realignment of our resources and structure for reduced operating expenses. See Note 4 for further details regarding the Realignment and Consolidation Plan. While the Realignment and Consolidation Plan improved operational efficiency and significantly reduced our costs, we have been unable to secure additional financing, which necessitated further measures to improve cash flow. On May 2, 2024, our board of directors approved a reduction in our workforce by approximately 80% of our employees (the “Workforce Reduction”) in order to preserve cash resources. The Workforce Reduction is expected to be completed over the next few weeks. We estimate that we will incur aggregate charges in connection with the Workforce Reduction of approximately $1.5 million, which relate to severance payments, benefits and related costs. The estimate of the charges that we expect to incur in connection with the Workforce Reduction, and the timing thereof, are subject to several assumptions and the actual amounts incurred may differ materially from these estimates. In addition, we may incur other charges or cash expenditures not currently contemplated due to unanticipated events that may occur, including in connection with the implementation of the Workforce Reduction. Management has concluded the likelihood that our plan to successfully obtain sufficient funding, or adequately reduce expenditures, while possible, is less than probable because these plans are not entirely within our control. We continue to evaluate all available strategic alternatives including, but not limited to, the divestiture of assets, additional financing security and/or the sale of the Company. There can be no assurance regarding the outcome of this process. Without an influx of cash to support operations, the Company faces financial hardship that may result in bankruptcy proceedings. Accordingly, we have concluded that substantial doubt exists about our ability to continue as a going concern for a period of at least twelve months from the date of issuance of these condensed consolidated interim financial statements. The accompanying condensed consolidated interim financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the ordinary course of business. The condensed consolidated interim financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might result from the outcome of the uncertainties described above. These adjustments may be material.

v3.24.1.1.u2

Realignment and Consolidation Plan	3 Months Ended
	Mar. 31, 2024
Restructuring and Related Activities [Abstract]
Realignment and Consolidation Plan	4. Realignment and Consolidation Plan As of March 31, 2024, as a result of the Realignment and Consolidation Plan approved by our board of directors on June 6, 2023, substantial progress has been made in restructuring our corporate structure to decrease operating expenses and concentrate on key areas with significant revenue potential, such as authentication, wide area motion imagery, battery materials, and transparent conductive films. During the three months ended March 31, 2024, we recognized $0.3 million of restructuring expense in relation to the plan, which consisted of severance payments for actual terminations under the Realignment and Consolidation Plan. The total expenses incurred from the plan's inception through March 31, 2024 amounted to $4.1 million. We accrue costs in connection with ongoing restructuring actions. These accruals include estimates primarily related to employee headcount, local statutory benefits, and other employee termination costs. We calculate severance obligations based on standard practices or the contractual obligations if applicable. As of March 31, 2024, we recorded $1.0 million in provisions for severance payments and contract termination costs when probable and estimable since we committed to the Realignment and Consolidation Plan. These accruals have been reviewed on a quarterly basis and changes to restructuring actions are appropriately recognized when identified. We also have one-time benefit arrangements with certain employees, which have been recorded in accordance with ASC 420 where a one-time termination benefit is accrued when the terms of the benefit arrangement is communicated to the affected employees and may be spread over a future service period through the termination date. Cash payments relating to restructuring costs in the three months ended March 31, 2024 were $0.4 million. The costs related to restructuring activities have been recorded in the restructuring expense in the condensed consolidated interim statement of operations and comprehensive loss.

v3.24.1.1.u2

Note Receivable	3 Months Ended
	Mar. 31, 2024
Receivables [Abstract]
Note Receivable	. Notes Receivable During 2021 and 2022, META loaned money to Next Bridge Hydrocarbons Inc. ("Next Bridge"), which was previously a wholly-owned subsidiary of META until the completion of the spin-off transaction on December 14, 2022, pursuant to a secured promissory note with principal amount of $15.0 million, or the 2021 Note, and unsecured note receivable for principal amount of $5.0 million, or the 2022 Note. The 2021 Note was partially secured by a combination of shares of META’s common stock and an interest in the Orogrande Project Property. In August 2023, we entered into a Loan Sale Agreement with Gregory McCabe, selling all rights, titles, interests, and obligations in the loans previously extended to Next Bridge Hydrocarbons Inc ("Next Bridge Notes Receivable"). This sale was finalized for cash consideration of $6.0 million, representing $24.0 million outstanding balance of the Next Bridge Notes Receivable as of the closing date, August 7, 2023. Concurrently, META and Mr. McCabe agreed on a Stock Purchase Agreement ("SPA"), whereby Mr. McCabe committed to purchasing $6.0 million of shares of our common stock beginning on September 1, 2023, in monthly amounts of $250,000 for the first six months and in monthly amounts of $500,000 for the next nine months thereafter, at a price per share equal to 120% of the 5-day VWAP on the trading day preceding the date of each such purchase. Mr. McCabe purchased 18,517 shares of our common stock for $0.5 million during the year ended December 31, 2023. On January 21, 2024, we entered into a Release Agreement with Mr. McCabe pursuant to which we and Mr. McCabe agreed to terminate the SPA. Under the terms of the Release Agreement, Mr. McCabe was relieved of any obligation to make additional stock purchases under the SPA. The terms of the Release Agreement require (i) a payment of $700,000 by Mr. McCabe to us, (ii) assignment to us of all stock purchases made by Mr. McCabe under the SPA and (iii) an additional payment of $700,000 by Mr. McCabe to us if our common stock achieves a certain target value within two years of the effective date of the Release Agreement. We received $700,000 in January 2024 and the 18,517 shares were reassigned to META, for which we recorded $0.1 million of treasury stock as of March 31, 2024.

v3.24.1.1.u2

Inventory	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Inventory	6. Inventory Inventory consists of photosensitive materials, lenses, laser protection film and finished eyewear, and is comprised of the following:     As of March 31,     As of December 31,       2024     2023   Raw materials   $ 512,897     $ 558,837   Supplies     10,693       10,747   Work in process     36,999       45,912   Finished goods     42,226       43,922   Inventory provision     (478,938 )     (490,671 ) Total inventory   $ 123,877     $ 168,747

v3.24.1.1.u2

Prepaid Expenses and Other Current Assets	3 Months Ended
	Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid Expenses and Other Current Assets	. Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consist of the following:     As of March 31,     As of December 31,       2024     2023   Prepaid expenses   $ 1,253,610     $ 1,476,981   Receivable for insurance proceeds (Note 19)     —       3,100,000   Other current assets     257,666       332,794   Taxes receivable     76,216       161,588   Total prepaid expenses and other current assets   $ 1,587,492     $ 5,071,363

v3.24.1.1.u2

Property, Plant and Equipment, Net	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Property, Plant and Equipment, Net	. Property, Plant and Equipment, net Property, plant and equipment consist of the following:     Useful life   As of March 31,     As of December 31,       (years)   2024     2023   Land   N/A   $ 439,115     $ 449,872   Building   25     5,060,849       5,184,826   Computer equipment   3-5     1,550,507       1,583,617   Computer software   1     796,670       815,777   Manufacturing equipment   2-5     23,608,611       23,979,024   Office furniture   5-7     895,962       914,265   Leasehold improvements   5-10     22,311,365       22,794,726   Enterprise Resource Planning software   5     197,560       202,400   Assets under construction   N/A     6,220,851       6,377,090             61,081,490       62,301,597   Accumulated depreciation and impairment         (43,232,617 )     (43,699,983 )       $ 17,848,873     $ 18,601,614   Depreciation expense was $0.3 million and $1.5 million for the three months ended March 31, 2024 and 2023, respectively.

v3.24.1.1.u2

Intangible Assets and Goodwill	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets and Goodwill	. Intangible Assets and Goodwill Intangible assets Intangible assets consist of the following:     Useful life   As of March 31,     As of December 31,       (years)   2024     2023   Patents   5-10   $ 42,862,050     $ 43,025,376   Trademarks         124,649       126,839   Developed technology   20     13,970,480       14,312,717   Customer contract   5     9,594,096       9,829,123           66,551,275       67,294,055   Accumulated amortization and impairment         (49,614,929 )     (49,263,754 )       $ 16,936,346     $ 18,030,301                     Amortization expense was $0.7 million and $1.8 million for the three months ended March 31, 2024 and 2023, respectively. Goodwill Goodwill is tested for impairment annually as of December 31 or more frequently when events or changes in circumstances indicate that impairment may have occurred. During the year ended December 31, 2023, we recorded $282.2 million of goodwill impairment as a result of a sustained decline in our market capitalization. Based on a quantitative interim goodwill impairment test performed at June 30, 2023, we concluded that the carrying value of the reporting unit was higher than its estimated fair value, which was determined using the market valuation method. This resulted in the impairment of the entire carrying value of goodwill as of June 30, 2023.

v3.24.1.1.u2

Long-Term Debt	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Long-Term debt	10. Long-Term Debt       As of March 31,     As of December 31,       2024     2023   ACOA Atlantic Innovation Fund ("AIF") 2015 interest-free loan(1)with a maximum contribution of CA$3,000,000. Annual repayments, commencing June 1, 2021, are calculated as a percentage of gross revenue for the preceding fiscal year, at Nil when gross revenues are less than CA$1,000,000, 5% when gross revenues are less than CA$10,000,000 and greater than CA$1,000,000, and CA$500,000 plus 1% of gross revenues when gross revenues are greater than CA$10,000,000. As of March 31, 2024, the amount of principal drawn down on the loan, net of repayments, is CA$2,122,882 (December 31, 2023 - CA$2,481,823).   $ 1,236,633     $ 1,486,966   ACOA BDP 2018 interest-free loan(2),(3) with a maximum contribution of CA$3,000,000, repayable in monthly repayments commencing June 1, 2021, of CA$31,250 until May 1, 2029. As of March 31, 2024, the amount of principal drawn down on the loan, net of repayments, is CA$1,937,500 (December 31, 2023 - CA$2,031,250).     990,836       1,047,122   ACOA PBS 2019 interest-free loan(2)with a maximum contribution of CA$100,000, repayable in monthly repayments commencing June 1, 2021, of CA$1,400 until May 1, 2027. As of March 31, 2024, the amount of principal drawn down on the loan, net of repayments, is CA$52,778 (December 31, 2023 - CA$56,944).     27,654       29,936   ACOA Regional Relief and Recovery Fund ("RRRF") 2020 interest-free loan with a maximum contribution of CA$390,000, repayable in monthly repayments commencing April 1, 2023, of CA$11,000 until April 1, 2026. As of March 31, 2024, the principal amount drawn down on the loan is CA$258,000 (December 31, 2023 - CA$291,000).     135,869       151,070   EDC 2022 interest-free loan(4) with a maximum contribution of CA$2,000,000 (CA$1,000,000 for building renovations and CA$1,000,000 for acquisition of equipment for Nanotech). Repayable in 60 monthly installments of CA$30,000, with the first repayment due in January 2026. As of March 31, 2024, the principal amount drawn down on the loan is CA$2,000,000 (December 31, 2023 - CA$1,800,000).     1,113,305       1,009,523       3,504,297       3,724,617   Less: current portion     545,215       801,628     $ 2,959,082     $ 2,922,989   (1) The carrying amount of the ACOA AIF loan is reviewed each reporting period and adjusted as required to reflect management’s best estimate of future cash flows, discounted at the original effective interest rate. (2) We were required to maintain a minimum balance of positive equity throughout the term of the loan. However, on November 14, 2019, ACOA waived this requirement for the period ending June 30, 2019 and for each period thereafter until the loan is fully repaid. (3) A portion of the ACOA BDP 2018 loan was used to finance the acquisition and construction of manufacturing equipment resulting in $425,872 that was recorded as deferred government assistance, which is being amortized over the useful life of the associated equipment. (4) The EDC 2022 loan was used to finance building renovations and equipment purchase resulting in CA$0.6 million of deferred government assistance as of March 31, 2024, which is being amortized over the useful life of the associated building and equipment.

v3.24.1.1.u2

Capital Stock	3 Months Ended
	Mar. 31, 2024
Stockholders' Equity Note [Abstract]
Capital Stock	11. Capital Stock Common stock Authorized: 10,000,000 common shares, $0.001 par value. During the three months ended March 31, 2024, 5,690 restricted stock units ("RSUs") have vested and settled into an equal number of common shares. In addition, 1,821 of vested Deferred Stock Units ("DSUs") have been redeemed during the three months ended March 31, 2024. February 2024 Offering On February 21, 2024, we completed a registered direct offering with an institutional investor of (i) 600,000 shares of our common stock, (ii) Pre-funded Warrants to purchase up to 250,000 shares of common stock, and (iii) February 2024 Warrants to purchase up to an aggregate of 850,000 shares of common stock (the "February 2024 Offering"). Each share of common stock and Pre-Funded Warrant was offered and sold together with an accompanying February 2024 Warrant at a combined price of $4.04 per share of common stock or $4.039 per Pre-Funded Warrant, as applicable. In connection with the February 2024 Offering, we received net proceeds of approximately $3.0 million, after deducting placement agent fees and estimated offering expenses payable by us. Each Pre-Funded Warrant and Warrant is exercisable at any time on or after the date of issuance to purchase one share of Common Stock at a price of either $0.001 per share, in the case of the Pre-Funded Warrants, or $3.91 per share, in the case of the Warrants. The Pre-Funded Warrants expire when they are exercised in full, and the Warrants expire five years from the date of issuance. As of March 31, 2024, we issued 250,000 shares of our common stock following the full exercise of the Pre-Funded Warrants. On February 19, 2024, in connection with, and as a condition to, the February 2024 Offering, we entered into the Letter Agreement with the institutional investor in the February 2024 Offering, pursuant to which we agreed to amend certain warrants issued on June 28, 2022 and amended on December 4, 2023 (the "June 2022 Warrants") and warrants issued on December 6, 2023 (the "December 2023 Warrants") held by the investor. The Letter Agreement applies to (i) June 2022 Warrants representing an aggregate of 74,074 shares of Common Stock and (ii) December 2023 Warrants representing an aggregate of 25,000 shares of Common Stock, in each case, after giving effect to the 1-for-100 reverse stock split the Company effected on January 29, 2024. Pursuant to the Letter Agreement, the exercise price per share of the amended June 2022 Warrants and December 2023 Warrants will automatically be reduced (if and only if such new exercise price on the repricing date is lower than the exercise price of the June 2022 Warrants and the December 2023 Warrants then in effect) to be the Minimum Price (as defined in Nasdaq Listing Rule 5635(d)) of the Common Stock on June 6, 2024. Based on ASC 815-40, which provides guidance as to how an issuer should account for a modification of the terms or conditions of a freestanding equity-classified written call option (i.e., warrant) that remains equity-classified after modification, we measured the effect of the Letter Agreement as the excess of the fair value of the amended June 2022 Warrants and December 2023 Warrant over the fair value of those warrants immediately before the Letter Agreement and recognized the excess as an equity issuance cost in connection with the February 2024 Offering. Accordingly, we recognized non-cash issuance cost of $0.2 million, which was included in Additional paid-in capital in the condensed consolidated interim balance sheet as of March 31, 2024. At-the-Market Equity Offering Program On February 10, 2023, we entered into a sales agreement, or the ATM Agreement, with an investment bank to conduct an "at-the-market" equity offering program, or the ATM, pursuant to which we may issue and sell, shares of our common stock, par value $0.001 per share, up to an aggregate of $100.0 million of shares of common stock, or the ATM Shares, from time to time. Under the ATM Agreement, we set the parameters for the sale of ATM Shares, including the number of ATM Shares to be issued, the time period during which sales are requested to be made, limitations on the number of ATM Shares that may be sold in any one trading day and any minimum price below which sales may not be made. Sales of the ATM Shares, if any, under the ATM Agreement may be made in transactions that are deemed to be “at-the-market offerings” as defined in Rule 415 under the Securities Act of 1933, as amended, or the Securities Act. During the three months ended March 31, 2023, we sold a total of 175,740 shares of our common stock under the ATM at a weighted average price of $60 per share, generating gross proceeds of $10.5 million and net proceeds of $10.0 million after offering expenses. By written notice dated September 5, 2023, Ladenburg terminated its participation as Sales Agent under the ATM Agreement, and accordingly the ATM Agreement was terminated. Warrants The following table summarizes the changes in warrants of the Company:     Number of             warrants     Amount   Balance, December 31, 2023     1,974,280     $ 39,269,867   Reverse stock split fractional shares adjustment     16     N/A   Issued     850,000       2,017,800   Exercised     (250,000 )     (589,784 ) Balance, March 31, 2024     2,574,296     $ 40,697,883

v3.24.1.1.u2

Stock-Based Payments	3 Months Ended
	Mar. 31, 2024
Share-Based Payment Arrangement [Abstract]
Stock-Based Payments	12. Stock-Based Payments On December 3, 2021, the stockholders of the Company approved the 2021 Equity Incentive Plan to utilize the 35,000 shares reserved and unissued under the Torchlight 2015 Stock Option and Grant Plan and the 64,457 shares reserved and unissued under the MMI 2018 Stock Option and Grant plan to set the number of shares reserved for issuance under the 2021 Equity Incentive Plan at 349,457 shares. The 2021 Equity Incentive Plan allows the grants of non-statutory stock options, restricted stock, RSUs, stock appreciation rights, performance units and performance shares to employees, directors, and consultants. DSU plan On March 28, 2013, we implemented a DSU Plan for our directors, employees and officers. Each unit is convertible at the option of the holder into one common share of the Company. Eligible individuals are entitled to receive all DSUs (including dividends and other adjustments) no later than December 1st of the first calendar year commencing after the time of termination of their services. The following table summarizes the change in DSUs of the Company:     Number of DSUs (#)     Weighted average grant date fair value   Outstanding, December 31, 2023     50,257     $ 29.57   Reverse stock split fractional shares adjustment     14     N/A   Redeemed     (1,821 )   $ 151.32   Outstanding, March 31, 2024     48,450     $ 25.03   RSU plan Each unit is convertible at the option of the holder into one common share of our shares upon meeting the vesting conditions. Total stock-based compensation expense related to RSUs included in the condensed consolidated interim statements of operations and comprehensive loss was as follows:     Three months ended March 31,       2024     2023   Cost of sales   $ (48,418 )   $ 143,905   Selling & marketing     13,439       120,544   General & administrative     61,552       403,207   Research & development     (26,248 )     419,021   Total expenses related to RSUs (1)   $ 325     $ 1,086,677   (1) Estimated forfeiture rate for RSUs as of March 31, 2024 is 20% compared to the estimated forfeiture rate of 0% for RSUs as of March 31, 2023. The following table summarizes the change in outstanding RSUs:     Number of RSUs #     Weighted average grant date fair value   Outstanding, December 31, 2023     90,725     $ 49.16   Reverse stock split fractional shares adjustment     60     N/A   Forfeited     (5,253 )   $ 99.94   Vested and settled     (5,690 )   $ 124.26   Outstanding, March 31, 2024     79,842     $ 40.52                 Vested but not yet settled, March 31, 2024     439     $ 121.00   Employee stock option plan Each stock option is convertible at the option of the holder into one common share upon payment of the exercise price. Total stock-based compensation expense related to stock options included in the condensed consolidated interim statements of operations and comprehensive loss was as follows:     Three months ended March 31,       2024     2023   Sales & marketing   $ —     $ 99,242   General & administrative     123,056       499,042   Research & development     126,033       317,379   Total expenses related to options (1)   $ 249,089     $ 915,663   (1) Estimated forfeiture rate for stock options as of March 31, 2024 is 8% compared to the estimated forfeiture rate of 0% for stock options as of March 31, 2023. The following table summarizes the change in our outstanding stock options:           Average     Average                 exercise     exercise                 price per     remaining   Aggregate       Number of options #     stock option     contractual term (years)   intrinsic value   Outstanding, December 31, 2023     189,540     $ 62.23     4.68   $ —   Reverse stock split fractional shares adjustment     33     N/A             Forfeited     (53,726 )   $ 63.54             Outstanding, March 31, 2024     135,847     $ 61.72     7.25   $ —                           Exercisable, March 31, 2024     79,176     $ 83.95     5.82   $ —                           Below is a summary of the outstanding options as of March 31, 2024 and December 31, 2024:     As of March 31,     As of December 31,       2024     2023   Range of exercise price   Number outstanding #     Number exercisable #     Number outstanding #     Number exercisable #    $12.00 - $27.00     93,070       44,641       124,383       75,457    $89.00 - $100.00     4,200       4,200       14,918       11,793    $117.00 - $126.00     10,376       5,294       15,029       8,446    $131.00 - $158.00     17,451       14,291       24,460       16,286    $197.00 - 200.00     10,750       10,750       10,750       9,374         135,847       79,176       189,540       121,356

v3.24.1.1.u2

Net Loss Per Share	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Net Loss Per Share	13. Net Loss Per Share The following table sets forth the calculation of basic and diluted net loss per share during the periods presented:     Three months ended March 31,       2024     2023   Numerator:             Net loss   $ (7,508,414 )   $ (18,668,678 ) Denominator:             Weighted-average shares, basic     6,180,363       3,688,793   Weighted-average shares, diluted     6,180,363       3,688,793   Net loss per share             Basic   $ (1.21 )   $ (5.06 ) Diluted   $ (1.21 )   $ (5.06 )               The following potentially dilutive shares were not included in the calculation of diluted shares above as the effect would have been anti-dilutive:     As of March 31,       2024     2023   Options     135,847       308,105   Warrants     2,574,296       399,209   RSUs     79,842       51,130   DSUs     48,450       39,102       2,838,435       797,546

v3.24.1.1.u2

Additional Cash Flow Information	3 Months Ended
	Mar. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Additional Cash Flow Information	14. Additional Cash Flow Information The net changes in non-cash working capital balances related to operations consist of the following:     Three months ended March 31,       2024     2023   Inventory   $ 40,970     $ 8,812   Accounts receivables and other receivables     (420,278 )     66,159   Prepaid expenses and other current assets     3,452,656       (792,684 ) Trade payables, accruals and other accruals     (3,578,613 )     (1,687,578 ) Restructuring costs accrual     (425,169 )     —   Due from related party     29,906       (60 ) Operating lease liabilities     (373,421 )     (318,919 )     $ (1,273,949 )   $ (2,724,270 )

v3.24.1.1.u2

Fair Value Measurements	3 Months Ended
	Mar. 31, 2024
Financial Instruments Disclosure [Abstract]
Fair Value Measurements	15. Fair Value Measurements We use a fair value hierarchy, based on the relative objectivity of inputs used to measure fair value, with Level 1 representing inputs with the highest level of objectivity and Level 3 representing the lowest level of objectivity. The fair values of cash and cash equivalents, restricted cash, short-term investments, grants and accounts receivable, due from related parties and trade and other payables approximate their carrying values due to the short-term nature of these instruments. The current portion of long-term debt has been included in the below table. The fair values of operating lease liabilities, and long-term debt would be classified at Level 3 in the fair value hierarchy, as each instrument is estimated based on unobservable inputs including discounted cash flows using the market rate, which is subject to similar risks and maturities with comparable financial instruments as at the reporting date. Carrying values and fair values of financial instruments that are not carried at fair value are as follows:     As of March 31,     As of December 31,       2024     2023   Financial liability   Carrying value     Fair value     Carrying value     Fair value   Funding obligation   $ 959,410     $ 959,410     $ 982,912     $ 982,912   Operating lease liabilities   $ 6,968,085     $ 9,315,009     $ 7,426,520     $ 9,782,069   Long-term debt   $ 3,504,297     $ 3,764,136     $ 3,724,617     $ 3,970,061

v3.24.1.1.u2

Revenue	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Revenue	16. Revenue We have one operating segment based on how management internally evaluates separate financial information, business activities and management responsibility. Revenue is disaggregated as follows:     Three months ended March 31,       2024     2023   Product sales   $ 85,169     $ 58,699   Licensing revenue     45,329       96,081       Contract revenue(1)     2,616,759       1,257,479       Other development revenue     525,000       —   Development revenue     3,141,759       1,257,479     $ 3,272,257     $ 1,412,259   (1) A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones. Refer to Note 18, Segment and Geographical Information, for revenues disaggregated by geography. Customer concentration A significant amount of our revenue is derived from contracts with major customers. For the three months ended March 31, 2024, revenue from those two customers, each representing more than 10% of the total revenue, accounted for $2.6 million, or 79.8%, and $0.4 million, or 11.5%, of total revenues, respectively. We currently derive a significant portion of our revenue from contract services with a G10 central bank. In August 2023 and September 2023, we were awarded $2.1 million and $6.2 million purchase orders, respectively, under this contract. Including those new purchase orders, we have received a total of $22.7 million in purchase orders under the development contract as of March 31, 2024. These contract services incorporate both nano-optic and optical thin film technologies and are focused on developing authentication features for future banknotes. For the three months ended March 31, 2023, revenue from one customer accounted for $1.3 million or 89.1% of total revenue.

v3.24.1.1.u2

Leases	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Leases	17. Leases There were no new significant lease agreements during the three months ended March 31, 2024 and 2023. In January 2024, by mutual agreement with Queen Mary University of London, the lease at the Queen Mary Innovation Centre in London was terminated without penalty. On January 15, 2024, the specified termination date of the lease agreement, we derecognized $0.3 million of lease liability and $0.3 million of ROU assets. Total operating lease expense included in the condensed consolidated interim statements of operations and comprehensive loss is as follows:     Three months ended March 31,       2024     2023   Operating lease expense   $ 318,844     $ 400,450   Short term lease expense     36,983       79,563   Variable and other lease expense     110,220       66,528    Total   $ 466,047     $ 546,541   We completed our evaluation of the provisions of ASC 842, Leases, and elected the practical expedient to not capitalize any leases with initial terms of less than twelve months on our balance sheet and include them as short-term lease expense in the condensed consolidated interim statements of operations and comprehensive loss. Future minimum payments under non-cancelable operating lease obligations were as follows as of March 31, 2024:  Remainder of 2024   $ 1,318,116    2025     1,719,548    2026     1,573,802    2027     1,159,226    2028     1,166,646   Thereafter     3,792,436   Total minimum lease payments     10,729,774   Less: interest     (3,761,689 ) Present value of net minimum lease payments     6,968,085   Less: current portion of lease liabilities     (1,296,404 ) Total long-term lease liabilities   $ 5,671,681

v3.24.1.1.u2

Segment and Geographic Information	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Segment and Geographic Information	18. Segment and Geographic Information We have a single operating segment and reportable segment. Our Chief Executive Officer was identified as the chief operating decision maker as of March 31, 2024. Our chief operating decision maker reviews financial information presented as one operating segment for the purpose of making decisions, allocating resources and assessing financial performance. Our net revenues by major geographic area (based on destination) were as follows:     Three months ended March 31,   Revenue by geography   2024     2023   United States                  Product sales   $ 8,512     $ 11,025        Development revenue     3,141,759       1,257,479        Licensing revenue     24,059       24,075   Canada                  Product sales     53,712       18,935        Licensing revenue     21,270       22,852   Other Countries                  Product sales     22,945       28,739        Licensing revenue     —       49,154   Total revenue   $ 3,272,257     $ 1,412,259                 Property, plant and equipment, net per geographic region were as follows:     As of March 31,     As of December 31,   Property, plant and equipment, net   2024     2023   United States   $ —     $ —   Canada     17,603,917       18,333,413   Other countries     244,956       268,201   Total property, plant and equipment, net   $ 17,848,873     $ 18,601,614

v3.24.1.1.u2

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	19. Commitments and Contingencies Legal matters Securities class action On January 3, 2022, a putative securities class action lawsuit was filed in the U.S. District Court for the Eastern District of New York captioned Maltagliati v. Meta Materials Inc., et al., No. 1:21-cv-07203, against us, our then current Chief Executive Officer, our then current Chief Financial Officer, Torchlight’s former Chairman of the board of directors, and Torchlight’s former Chief Executive Officer. On January 26, 2022, a similar putative securities class action lawsuit was filed in the U.S. District Court for the Eastern District of New York captioned McMillan v. Meta Materials Inc., et al., No. 1:22-cv-00463. The McMillan complaint names the same defendants and asserts the same claims on behalf of the same purported class as the Maltagliati complaint. The complaints, purportedly brought on behalf of all purchasers of our publicly traded securities from September 21, 2020 through and including December 14, 2021, assert claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934, or the Exchange Act, arising primarily from a short-seller report and statements related to our business combination with Torchlight. The complaints seek unspecified compensatory damages and reasonable costs and expenses, including attorneys’ fees. On July 15, 2022, the Court consolidated these actions under the caption In re Meta Materials Inc. Securities Litigation, No. 1:21-cv-07203, appointed lead plaintiffs and approved the lead plaintiffs’ selection of lead counsel. Lead plaintiffs filed a consolidated complaint on August 29, 2022. We moved to dismiss that complaint on October 13, 2022. The Court granted our motion to dismiss on September 29, 2023 and entered judgment on the defendants' behalf on October 3, 2023. On October 27, 2023, the lead plaintiffs filed a motion to vacate judgment and for leave to amend the pleadings. On October 27, 2023, the lead plaintiffs filed a motion to vacate judgment and for leave to amend the pleadings. This motion attached a proposed amended consolidated complaint which, among other things, shortened the class period to December 14, 2021, removed the Securities Act claims, removed the former Chief Financial Officer as a defendant, and removed certain alleged misrepresentations. We filed an opposition to the motion to vacate judgment and for leave to amend on November 13, 2023 and lead plaintiffs filed a reply on November 27, 2023. On December 20, 2023, we reached an agreement to settle this securities class and the Nevada Shareholder Action (described below) on a class-wide basis for a combined $3.0 million (“Proposed Class Actions Settlement”). On January 19, 2024, the parties executed a formal Stipulation of Settlement and the plaintiffs filed a motion for preliminary approval of the Proposed Class Actions Settlement. As of March 31, 2024, the $3.0 million owed to the plaintiffs had been fully paid, with $2.85 million of this amount covered directly by our insurers. Shareholder derivative action On January 14, 2022, a shareholder derivative action was filed in the U.S. District Court for the Eastern District of New York captioned Hines v. Palikaras, et al., No. 1:22-cv-00248. The complaint names as defendants certain of our current officers and directors, certain former Torchlight officers and directors, and us (as nominal defendant). The complaint, purportedly brought on our behalf, asserts claims under Section 14(a) of the Exchange Act, contribution claims under Sections 10(b) and 21D of the Exchange Act, and various state law claims such as breach of fiduciary duties and unjust enrichment. The complaint seeks, among other things, unspecified compensatory damages in our favor, certain corporate governance related actions, and an award of costs and expenses to the derivative plaintiff, including attorneys’ fees. On March 9, 2022, the Court entered a stipulated order staying this action until there is a ruling on a motion to dismiss in the securities class action. Nevada shareholder action On September 21, 2023, a putative shareholder class action was filed in the Eighth Judicial District Court Clark County, Nevada captioned Denton v. Palikaras, et al., No. A-23-878134-C. The complaint names us as defendants along with certain of our former officers and certain former Torchlight officers and directors. The complaint alleges claims for breach of fiduciary duty and aiding and abetting breach of fiduciary duty, arising from our business combination with Torchlight. The complaint seeks, among other things, unspecified damages, interest, and an award of costs and fees to plaintiffs, including attorneys’ fees. On December 20, 2023, we reached an agreement to settle the Nevada Shareholder Action and the security class action described above on a class-wide basis for a combined $3.0 million, of which $2.85 million was paid by our insurers. On January 19, 2024, the parties executed a formal Stipulation of Settlement and the plaintiffs filed a motion for preliminary approval of the Proposed Class Actions Settlement. The settlement is still subject to final approval of the court, however on February 6, 2024, the court granted preliminary approval of the Proposed Class Actions Settlement. Furthermore, as detailed in the Securities Class Action section above, the entire settlement amount had been fully paid as of March 31, 2024. Westpark Capital Group On July 25, 2022, Westpark Capital Group, LLC ("Westpark") filed a complaint in Los Angeles County Superior Court against us for breach of contract, alleging that it is owed a $0.5 million commission as a placement agent with respect to our June 2022 direct offering. On August 31, 2022, we filed an answer to the complaint. We dispute that WestPark Capital Group placed the investor in the direct offering and is owed a commission. We recorded a liability of $0.3 million related to the claim from Westpark in Accruals and other payables in the condensed consolidated interim balance sheet as of March 31, 2024 based on our best estimate of the outflow required to settle the claim. SEC investigation In September 2021, we received a subpoena from the Securities and Exchange Commission, Division of Enforcement, in a matter captioned In the Matter of Torchlight Energy Resources, Inc. The subpoena requested that we produce certain documents and information related to, among other things, the merger involving Torchlight. On July 20, 2023, the enforcement staff of the SEC provided us, Torchlight's former Chief Executive Officer, John Brda, and our former Chief Executive Officer, George Palikaras, with Wells Notices relating to the SEC investigation (the "Wells Notice"). The Wells Notices each state that the SEC staff has made a preliminary determination to recommend that the SEC file a civil enforcement action against the recipients alleging violations of certain provisions of the U.S. federal securities laws. Specifically, the Wells Notice received by us states that the proposed action would allege violations of Section 17(a) of the Securities Act; Sections 10(b), 13(a), 13(b)(2)(A), 13(b)(2)(B) and 14(a) of the Exchange Act of 1934 and Rules 10b-5 and 14a-9 thereunder; and Regulation FD. A Wells Notice is neither a formal charge of wrongdoing nor a final determination that the recipient has violated any law. It allows the recipients the opportunity to address the issues raised by the enforcement staff before a decision is made by the SEC on whether to authorize any enforcement action. If the SEC were to authorize an action against us and/or any of the individuals, it could seek an injunction against future violations of provisions of the federal securities laws, the imposition of civil monetary penalties, and other equitable relief within the SEC’s authority. The SEC could also seek an order barring the individuals from serving as an officer or director of a public company. In addition, the SEC could seek disgorgement of an amount that may exceed our ability to pay. We have made an offer of settlement to the Staff of the SEC’s Division of Enforcement to resolve the matter. The Proposed SEC Settlement is subject to approval by the SEC Commissioners. We cannot predict whether or when the Proposed SEC Settlement will be approved. If the Commissioners approve the Proposed SEC Settlement, the Commission will enter a cease- and-desist order (the “Order”) in connection with certain antifraud, reporting, books and records, and internal accounting control provisions of the securities laws. Under the terms of the Proposed SEC Settlement, we would neither admit nor deny the findings in the Order. If approved, in connection with the Proposed SEC Settlement, we will pay a civil money penalty in an amount of $1.0 million in four (4) installments over the period of one (1) year pursuant to an agreed upon payment plan. We recorded the $1.0 million in Accruals and other payables in the condensed consolidated interim balance sheet as of March 31, 2024. Claim for breach of contract On February 8, 2024, M.R.S. Construction Limited (“MRS”) filed a notice of action in the Supreme Court of Nova Scotia against Metamaterial Technologies Canada Inc., our subsidiary, for breach of contract, alleging that it is owed CA$1.0 million in fees. The case is currently pending. As of March 31, 2024, we have approximately $0.5 million of unpaid balance recorded in the Trade payables of our condensed consolidated interim balance sheet. Claim for breach of contract filed in British Columbia On March 25, 2024, Canadian Foundation for Sustainable Development Technology (“SDTC”) filed a notice of action in the Supreme Court of British Columbia against Metamaterial Technologies Canada Inc., our subsidiary, for breach of contract, alleging that it is owed $0.2 million in fees. The case is currently pending. We recorded the $0.2 million in Accruals and other payables in the condensed consolidated interim balance sheet as of March 31, 2024. Securities class action - Targgart On March 15, 2024, a securities class action lawsuit was filed in the U.S. District Court for the Eastern District of New York captioned Todd Targgart v. Next Bridge Hydrocarbons, Inc. (Next Bridge), Ken Rice, George Palikaras, Robert L. Cook, Clifton Dubose, Jr., Joseph Dewoody, Lucas T. Hawkins, Delvina Oelkers, Mia Pitts, Kristin Whitley and Gregory McCabe, No. 1:24-cv-01927, against Next Bridge, a former subsidiary of the Company, our former Chief Executive Officer and then President of Next Bridge, our former Chief Financial Officer and then CFO of Next Bridge, Torchlight’s former Chairman of its board of directors and directors of Next Bridge subsequent to its spin-off from the Company. The complaint, purportedly brought on behalf of all acquirors of Next Bridge shares on or around December 14, 2022, assert claims under Sections 11 and 15 of the Securities Exchange Act of 1934, or the Exchange Act, arising primarily from statements made in the registration statement filed in connection with the Company’s spin-off of Next Bridge. The complainants seek unspecified compensatory damages and reasonable costs and expenses, including attorneys’ fees. Although the Company was not named in the complaint, certain defendants have made indemnification demands on the Company. The case is currently pending. No financial impact of a loss contingency has been recognized in the condensed consolidated interim financial statements, as this matter does not meet the required criteria of being both probable and reasonably estimated at this time. Labour Standards Complaint On April 12, 2024, a complaint was filed in the Nova Scotia Labour Standards Division, against the Company by George Palikaras, the former President and CEO of the Company. The complaint asserts claims under Section 21 of the Labour Standards Code and seeks complainant’s reinstatement or alternatively, damages in lieu of reinstatement. The case is currently pending. No financial impact of a loss contingency has been recognized in the condensed consolidated interim financial statements, as this matter does not meet the required criteria of being both probable and reasonably estimated at this time. Contractual commitments and purchase obligations We are party to various contractual obligations. Some of these obligations are reflected in our financial statements, such as liabilities from debt obligations and commitment in relation to Realignment and Consolidated Plan, while other obligations, such as purchase obligations, are not reflected on our condensed consolidated interim balance sheets. The following table and discussion summarizes our contractual cash obligations other than the lease payment obligations shown in the Note 17, Leases, as of March 31, 2024, for each of the periods presented:   Long-term debt     Other contractual commitment     Total    Remainder of 2024 $ 663,586     $ 1,146,973     $ 1,810,559    2025   999,789       116,009       1,115,798    2026   1,183,560       29,002       1,212,562    2027   577,081       —       577,081    2028   571,939       —       571,939    Thereafter   705,720       —       705,720   $ 4,701,675     $ 1,291,984     $ 5,993,659   Other contractual commitments are legally enforceable agreements to purchase goods or services that have fixed or minimum quantities and fixed or minimum variable price provisions. Amounts in the schedule above approximate the timing of the underlying obligations. Included are the following: a) In September 2022, we entered into a supply agreement with an American paint and coatings company to purchase at least 20,000 pounds of raw materials (the "Minimum Purchase Obligation") in the three years from September 29, 2022. The total contract price for the minimum purchase obligation is $1.1 million. As of March 31, 2024, we have $0.7 million in non-cancelable orders, with $0.4 million of this amount recorded under Accruals and other payables in the condensed consolidated interim balance sheet. b) On September 30, 2022, we entered into an amended supply agreement with a German manufacturer who supplies holographic raw materials for the three years from November 1, 2020. As of March 31, 2024, we have a non-cancelable order of $0.3 million. Other commitments not included in the contractual cash obligations table above a) During 2018, we arranged a guarantee/standby letter of credit with RBC in favor of Satair A/S for $0.5 million in relation to an advance payment received. In the event we fail to deliver the product as per the contract or refuse to accept the return of the product as per the buyback clause of the contract or fails to repay the advance payment in accordance with the conditions of the agreement signed with Satair on September 18, 2018, Satair shall draw from the letter of credit with RBC. Borrowings from the letter of credit with RBC are repayable on demand. The letter of credit is secured by restricted cash. b) On January 15, 2021, Nanotech purchased six patents for $0.1 million and we agreed to share 10% of any revenues related to the patents received from a specific customer for a period of two years and ongoing royalties of 3% to 6% on other revenues derived from these patents for a period of five years. There were no royalties during the three months ended March 31, 2024 (March 31, 2023 - $Nil). In March 2022, we adopted the Vlepsis Business Profit Sharing Plan whereby at the end of each year, we will calculate the profits from the Vlepsis business, if any, with certain of the Vlepsis employees. Annually, on the 29th of March for each year between 2023 and 2029, we will measure and allocate a bonus pool equivalent to fifty percent (50%) of the net profits of Vlepsis. These profits are defined as the total revenue generated from the full spectrum of Vlepsis' technological and service operations, including, but not limited to, sales, maintenance, customer support, system customization, intellectual property licensing, franchising, and leasing plus revenues from contracted backlog sales of Vlepsis Business technologies and services, less all pertinent direct costs such as overhead, salaries, and service provision costs by the Company. We have not yet had any profits from this business, but if we ever do, then this obligation to share such profits will impact our return on investment in VLEPSIS® technology and require more time to recoup our expenses and show a return.

v3.24.1.1.u2

Subsequent Events	3 Months Ended
	Mar. 31, 2024
Subsequent Events [Abstract]
Subsequent Events	20. Subsequent Events Workforce Reduction As disclosed above in Note 3, Going Concern, on May 2, 2024, our board of directors approved a reduction in our workforce by approximately 80% of our employees (the Workforce Reduction) in order to preserve cash resources. The Workforce Reduction is expected to be completed over the next few weeks. We continue to evaluate all available strategic alternatives including, but not limited to, the divestiture of assets, additional financing security and/or the sale of the Company. There can be no assurance regarding the outcome of this process. Without an influx of cash to support operations, we face financial hardship that may result in shuttering facilities and/or bankruptcy proceedings. Labour Standards Complaint On April 12, 2024, George Palikaras, the former President and CEO of the Company, filed a complaint with the Nova Scotia Labour Standards Division, asserting claims under Section 21 of the Labour Standards Code and seeking reinstatement or, alternatively, damages in lieu of reinstatement. The case is currently pending.

v3.24.1.1.u2

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Basis of Presentation	Basis of presentation These unaudited condensed consolidated interim financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States of America, or U.S. GAAP. Our fiscal year-end is December 31. The unaudited condensed consolidated interim financial statements include the accounts of Meta Materials Inc. and its wholly-owned subsidiaries. All significant intercompany balances and transactions have been eliminated on consolidation. These unaudited condensed consolidated interim financial statements do not include all of the information and notes required by U.S. GAAP for annual financial statements. Accordingly, these unaudited condensed consolidated interim financial statements should be read in conjunction with our audited consolidated financial statements and notes for the years ended December 31, 2023 and 2022, filed with the SEC.
Reverse Stock Split	Reverse Stock Split On January 26, 2024, we filed a Certificate of Change with the Nevada Secretary of State to effect a reverse stock split of our common stock at a rate of 1-for-100 (the "Reverse Stock Split"), which became effective as of January 29, 2024 (the "Effective Date"). The Reverse Stock Split was approved by the board of directors in accordance with Nevada law. The Reverse Stock Split did not have any impact on the par value of common stock. On the Effective Date, every one hundred shares of Common Stock issued and outstanding were automatically combined into one share of Common Stock, without any change in the par value per share. As the per-share par value did not change, we reclassified $0.5 million from Common Stock to Additional Paid-in-Capital on the Effective Date. The exercise prices and the number of shares issuable upon exercise of outstanding stock options, equity awards and warrants, and the number of shares available for future issuance under the equity incentive plans were adjusted in accordance with their respective terms. The Reverse Stock Split affected all stockholders uniformly and did not alter any stockholder’s percentage interest in our Common Stock. We did not issue any fractional shares in connection with the Reverse Stock Split. Instead, fractional shares were rounded up to the next largest whole number, resulting in the issuance of 177,686 shares upon the Effective Date. The Reverse Stock Split did not modify the relative rights or preferences of the Common Stock. Unless otherwise indicated, all issued and outstanding shares of common stock and all outstanding securities entitling their holders to purchase shares of our common stock or acquire shares of our common stock, including stock options, restricted stock units, and warrants per share data, share prices and exercise prices, as required by the terms of those securities, have been adjusted retroactively to reflect the Reverse Stock Split. The following table provides details on how the Reverse Stock Split affects our outstanding common stock and the calculation of Earnings Per Share:     As of March 31, 2023       Post-Reverse Stock Split     Pre-Reverse Stock Split    Number of shares authorized     10,000,000       1,000,000,000    Number of shares issues and outstanding     3,837,449       383,744,889    Weighted average number of shares outstanding - basic and diluted     3,688,793       368,879,341               Three months ended       March 31, 2023     Post-Reverse Stock Split     Pre-Reverse Stock Split    Basic and diluted loss per share   $ (5.06 )   $ (0.05 )
Reclassification	Reclassification – Certain prior year amounts have been reclassified in the accompanying unaudited condensed consolidated interim financial statements to conform to the current period presentation: • Licensing revenue is reported in a separate line under Revenue in the accompanying unaudited condensed statements of operations and comprehensive loss. Previously, Licensing revenue was reported as part of Development revenue. Amounts related to Licensing revenue for the three months ended March 31, 2023 have been separately presented throughout this Quarterly Report to reflect this reclassification of Licensing revenue to conform to the current period presentation. There are no changes in total Revenue and Gross profit. • Depreciation and amortization expenses and stock-based compensation expense are reported in a separate line under Cost of sales and Operating expenses in the accompanying unaudited condensed consolidated interim statements of operations and comprehensive loss. Previously, those expenses were reported as a same line item under Cost of sales, Sales & marketing, General & administrative and Research & development. Amounts related to depreciation and amortization expenses and stock-based compensation expense for the three months ended March 31, 2023 have been separately presented throughout this Quarterly Report to reflect this reclassification of depreciation and amortization expenses and stock-based compensation expense to conform to the current period presentation. There are no changes in total Cost of sales, Gross profit and Operating expenses. • Realized gain (loss) on foreign exchange, net and Unrealized gain (loss) on foreign exchange, net are reported in a separate line under Other income (expense), net in the accompanying unaudited condensed consolidated interim statements of operations and comprehensive loss. Previously, those expenses were reported as a single line, Gain (loss) on foreign exchange, net, under Other income (expense), net in the unaudited condensed consolidated interim statements of operations and comprehensive loss. Amounts related to Gain (loss) on foreign exchange, net, for the three months ended March 31, 2023 have been separately presented throughout this Quarterly Report to reflect this reclassification of Realized gain (loss) on foreign exchange, net and Unrealized gain (loss) on foreign exchange to conform to the current period presentation. There are no changes in total Other income (expense), net.
Recently Adopted/Not Yet Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements As of March 31, 2024 and for the period then ended, there were no recently adopted accounting standards that had a material impact on our consolidated financial statements. Accounting Pronouncements Not Yet Adopted ASU 2023-07 In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, which requires public entities to disclose information about their reportable segments’ significant expenses and other segment items on an interim and annual basis. Public entities with a single reportable segment are required to apply the disclosure requirements in ASU 2023-07, as well as all existing segment disclosures and reconciliation requirements in Accounting Standards Codification ("ASC") 280 on an interim and annual basis. ASU 2023-07 is effective for fiscal years beginning after December 15, 2023, and for interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. The Company is currently evaluating the impact of adopting ASU 2023-07. ASU 2023-09 In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures, which requires public entities, on an annual basis, to provide disclosure of specific categories in the rate reconciliation, as well as disclosure of income taxes paid disaggregated by jurisdiction. ASU 2023-09 is effective for fiscal years beginning after December 15, 2024, with early adoption permitted. We do not anticipate the adoption of this standard will have a material effect on our consolidated financial statements and related disclosures.

v3.24.1.1.u2

Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2024
Accounting Policies [Abstract]
Schedule of Reverse Stock Split	The following table provides details on how the Reverse Stock Split affects our outstanding common stock and the calculation of Earnings Per Share:     As of March 31, 2023       Post-Reverse Stock Split     Pre-Reverse Stock Split    Number of shares authorized     10,000,000       1,000,000,000    Number of shares issues and outstanding     3,837,449       383,744,889    Weighted average number of shares outstanding - basic and diluted     3,688,793       368,879,341               Three months ended       March 31, 2023     Post-Reverse Stock Split     Pre-Reverse Stock Split    Basic and diluted loss per share   $ (5.06 )   $ (0.05 )

v3.24.1.1.u2

Inventory (Tables)	3 Months Ended
	Mar. 31, 2024
Inventory Disclosure [Abstract]
Summary of Inventory	Inventory consists of photosensitive materials, lenses, laser protection film and finished eyewear, and is comprised of the following:     As of March 31,     As of December 31,       2024     2023   Raw materials   $ 512,897     $ 558,837   Supplies     10,693       10,747   Work in process     36,999       45,912   Finished goods     42,226       43,922   Inventory provision     (478,938 )     (490,671 ) Total inventory   $ 123,877     $ 168,747

v3.24.1.1.u2

Prepaid Expenses and Other Current Assets (Tables)	3 Months Ended
	Mar. 31, 2024
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Summary of Prepaid Expenses and Other Current Assets	Prepaid expenses and other current assets consist of the following:     As of March 31,     As of December 31,       2024     2023   Prepaid expenses   $ 1,253,610     $ 1,476,981   Receivable for insurance proceeds (Note 19)     —       3,100,000   Other current assets     257,666       332,794   Taxes receivable     76,216       161,588   Total prepaid expenses and other current assets   $ 1,587,492     $ 5,071,363

v3.24.1.1.u2

Property, Plant and Equipment, Net (Tables)	3 Months Ended
	Mar. 31, 2024
Property, Plant and Equipment [Abstract]
Schedule of Property, Plant and Equipment	Property, plant and equipment consist of the following:     Useful life   As of March 31,     As of December 31,       (years)   2024     2023   Land   N/A   $ 439,115     $ 449,872   Building   25     5,060,849       5,184,826   Computer equipment   3-5     1,550,507       1,583,617   Computer software   1     796,670       815,777   Manufacturing equipment   2-5     23,608,611       23,979,024   Office furniture   5-7     895,962       914,265   Leasehold improvements   5-10     22,311,365       22,794,726   Enterprise Resource Planning software   5     197,560       202,400   Assets under construction   N/A     6,220,851       6,377,090             61,081,490       62,301,597   Accumulated depreciation and impairment         (43,232,617 )     (43,699,983 )       $ 17,848,873     $ 18,601,614

v3.24.1.1.u2

Intangible Assets and Goodwill (Tables)	3 Months Ended
	Mar. 31, 2024
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intangibles, Net	Intangible assets consist of the following:     Useful life   As of March 31,     As of December 31,       (years)   2024     2023   Patents   5-10   $ 42,862,050     $ 43,025,376   Trademarks         124,649       126,839   Developed technology   20     13,970,480       14,312,717   Customer contract   5     9,594,096       9,829,123           66,551,275       67,294,055   Accumulated amortization and impairment         (49,614,929 )     (49,263,754 )       $ 16,936,346     $ 18,030,301

v3.24.1.1.u2

Long-Term Debt (Tables)	3 Months Ended
	Mar. 31, 2024
Debt Disclosure [Abstract]
Summary of Long Term Debt	As of March 31,     As of December 31,       2024     2023   ACOA Atlantic Innovation Fund ("AIF") 2015 interest-free loan(1)with a maximum contribution of CA$3,000,000. Annual repayments, commencing June 1, 2021, are calculated as a percentage of gross revenue for the preceding fiscal year, at Nil when gross revenues are less than CA$1,000,000, 5% when gross revenues are less than CA$10,000,000 and greater than CA$1,000,000, and CA$500,000 plus 1% of gross revenues when gross revenues are greater than CA$10,000,000. As of March 31, 2024, the amount of principal drawn down on the loan, net of repayments, is CA$2,122,882 (December 31, 2023 - CA$2,481,823).   $ 1,236,633     $ 1,486,966   ACOA BDP 2018 interest-free loan(2),(3) with a maximum contribution of CA$3,000,000, repayable in monthly repayments commencing June 1, 2021, of CA$31,250 until May 1, 2029. As of March 31, 2024, the amount of principal drawn down on the loan, net of repayments, is CA$1,937,500 (December 31, 2023 - CA$2,031,250).     990,836       1,047,122   ACOA PBS 2019 interest-free loan(2)with a maximum contribution of CA$100,000, repayable in monthly repayments commencing June 1, 2021, of CA$1,400 until May 1, 2027. As of March 31, 2024, the amount of principal drawn down on the loan, net of repayments, is CA$52,778 (December 31, 2023 - CA$56,944).     27,654       29,936   ACOA Regional Relief and Recovery Fund ("RRRF") 2020 interest-free loan with a maximum contribution of CA$390,000, repayable in monthly repayments commencing April 1, 2023, of CA$11,000 until April 1, 2026. As of March 31, 2024, the principal amount drawn down on the loan is CA$258,000 (December 31, 2023 - CA$291,000).     135,869       151,070   EDC 2022 interest-free loan(4) with a maximum contribution of CA$2,000,000 (CA$1,000,000 for building renovations and CA$1,000,000 for acquisition of equipment for Nanotech). Repayable in 60 monthly installments of CA$30,000, with the first repayment due in January 2026. As of March 31, 2024, the principal amount drawn down on the loan is CA$2,000,000 (December 31, 2023 - CA$1,800,000).     1,113,305       1,009,523       3,504,297       3,724,617   Less: current portion     545,215       801,628     $ 2,959,082     $ 2,922,989   (1) The carrying amount of the ACOA AIF loan is reviewed each reporting period and adjusted as required to reflect management’s best estimate of future cash flows, discounted at the original effective interest rate. (2) We were required to maintain a minimum balance of positive equity throughout the term of the loan. However, on November 14, 2019, ACOA waived this requirement for the period ending June 30, 2019 and for each period thereafter until the loan is fully repaid. (3) A portion of the ACOA BDP 2018 loan was used to finance the acquisition and construction of manufacturing equipment resulting in $425,872 that was recorded as deferred government assistance, which is being amortized over the useful life of the associated equipment. (4) The EDC 2022 loan was used to finance building renovations and equipment purchase resulting in CA$0.6 million of deferred government assistance as of March 31, 2024, which is being amortized over the useful life of the associated building and equipment.

v3.24.1.1.u2

Capital Stock (Tables)	3 Months Ended
	Mar. 31, 2024
Class of Warrant or Right [Line Items]
Summary of Changes in Warrants	The following table summarizes the changes in warrants of the Company:     Number of             warrants     Amount   Balance, December 31, 2023     1,974,280     $ 39,269,867   Reverse stock split fractional shares adjustment     16     N/A   Issued     850,000       2,017,800   Exercised     (250,000 )     (589,784 ) Balance, March 31, 2024     2,574,296     $ 40,697,883

v3.24.1.1.u2

Stock-Based Payments (Tables)	3 Months Ended
	Mar. 31, 2024
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of stock options outstanding	Below is a summary of the outstanding options as of March 31, 2024 and December 31, 2024:     As of March 31,     As of December 31,       2024     2023   Range of exercise price   Number outstanding #     Number exercisable #     Number outstanding #     Number exercisable #    $12.00 - $27.00     93,070       44,641       124,383       75,457    $89.00 - $100.00     4,200       4,200       14,918       11,793    $117.00 - $126.00     10,376       5,294       15,029       8,446    $131.00 - $158.00     17,451       14,291       24,460       16,286    $197.00 - 200.00     10,750       10,750       10,750       9,374         135,847       79,176       189,540       121,356
Summary of change in share outstanding options	The following table summarizes the change in our outstanding stock options:           Average     Average                 exercise     exercise                 price per     remaining   Aggregate       Number of options #     stock option     contractual term (years)   intrinsic value   Outstanding, December 31, 2023     189,540     $ 62.23     4.68   $ —   Reverse stock split fractional shares adjustment     33     N/A             Forfeited     (53,726 )   $ 63.54             Outstanding, March 31, 2024     135,847     $ 61.72     7.25   $ —                           Exercisable, March 31, 2024     79,176     $ 83.95     5.82   $ —
Summary of change in outstanding share RSUs	The following table summarizes the change in outstanding RSUs:     Number of RSUs #     Weighted average grant date fair value   Outstanding, December 31, 2023     90,725     $ 49.16   Reverse stock split fractional shares adjustment     60     N/A   Forfeited     (5,253 )   $ 99.94   Vested and settled     (5,690 )   $ 124.26   Outstanding, March 31, 2024     79,842     $ 40.52                 Vested but not yet settled, March 31, 2024     439     $ 121.00
DSU Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of change in outstanding share DSU's	The following table summarizes the change in DSUs of the Company:     Number of DSUs (#)     Weighted average grant date fair value   Outstanding, December 31, 2023     50,257     $ 29.57   Reverse stock split fractional shares adjustment     14     N/A   Redeemed     (1,821 )   $ 151.32   Outstanding, March 31, 2024     48,450     $ 25.03
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of stock-based compensation expenses	Total stock-based compensation expense related to RSUs included in the condensed consolidated interim statements of operations and comprehensive loss was as follows:     Three months ended March 31,       2024     2023   Cost of sales   $ (48,418 )   $ 143,905   Selling & marketing     13,439       120,544   General & administrative     61,552       403,207   Research & development     (26,248 )     419,021   Total expenses related to RSUs (1)   $ 325     $ 1,086,677   (1) Estimated forfeiture rate for RSUs as of March 31, 2024 is 20% compared to the estimated forfeiture rate of 0% for RSUs as of March 31, 2023.
Employee Stock Option Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Summary of stock-based compensation expenses	Total stock-based compensation expense related to stock options included in the condensed consolidated interim statements of operations and comprehensive loss was as follows:     Three months ended March 31,       2024     2023   Sales & marketing   $ —     $ 99,242   General & administrative     123,056       499,042   Research & development     126,033       317,379   Total expenses related to options (1)   $ 249,089     $ 915,663   (1) Estimated forfeiture rate for stock options as of March 31, 2024 is 8% compared to the estimated forfeiture rate of 0% for stock options as of March 31, 2023.

v3.24.1.1.u2

Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2024
Earnings Per Share [Abstract]
Summary Basic and Diluted Net Loss Per Share	The following table sets forth the calculation of basic and diluted net loss per share during the periods presented:     Three months ended March 31,       2024     2023   Numerator:             Net loss   $ (7,508,414 )   $ (18,668,678 ) Denominator:             Weighted-average shares, basic     6,180,363       3,688,793   Weighted-average shares, diluted     6,180,363       3,688,793   Net loss per share             Basic   $ (1.21 )   $ (5.06 ) Diluted   $ (1.21 )   $ (5.06 )
Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive shares were not included in the calculation of diluted shares above as the effect would have been anti-dilutive:     As of March 31,       2024     2023   Options     135,847       308,105   Warrants     2,574,296       399,209   RSUs     79,842       51,130   DSUs     48,450       39,102       2,838,435       797,546

v3.24.1.1.u2

Additional Cash Flow Information (Tables)	3 Months Ended
	Mar. 31, 2024
Supplemental Cash Flow Elements [Abstract]
Summary Of Cash Flow, Operating Capital	The net changes in non-cash working capital balances related to operations consist of the following:     Three months ended March 31,       2024     2023   Inventory   $ 40,970     $ 8,812   Accounts receivables and other receivables     (420,278 )     66,159   Prepaid expenses and other current assets     3,452,656       (792,684 ) Trade payables, accruals and other accruals     (3,578,613 )     (1,687,578 ) Restructuring costs accrual     (425,169 )     —   Due from related party     29,906       (60 ) Operating lease liabilities     (373,421 )     (318,919 )     $ (1,273,949 )   $ (2,724,270 )

v3.24.1.1.u2

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2024
Financial Instruments Disclosure [Abstract]
Summary of Fair Value of Financial Instruments	Carrying values and fair values of financial instruments that are not carried at fair value are as follows:     As of March 31,     As of December 31,       2024     2023   Financial liability   Carrying value     Fair value     Carrying value     Fair value   Funding obligation   $ 959,410     $ 959,410     $ 982,912     $ 982,912   Operating lease liabilities   $ 6,968,085     $ 9,315,009     $ 7,426,520     $ 9,782,069   Long-term debt   $ 3,504,297     $ 3,764,136     $ 3,724,617     $ 3,970,061

v3.24.1.1.u2

Revenue (Tables)	3 Months Ended
	Mar. 31, 2024
Revenue from Contract with Customer [Abstract]
Summary of Revenue Disaggregated	Revenue is disaggregated as follows:     Three months ended March 31,       2024     2023   Product sales   $ 85,169     $ 58,699   Licensing revenue     45,329       96,081       Contract revenue(1)     2,616,759       1,257,479       Other development revenue     525,000       —   Development revenue     3,141,759       1,257,479     $ 3,272,257     $ 1,412,259   (1) A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones.

v3.24.1.1.u2

Leases (Tables)	3 Months Ended
	Mar. 31, 2024
Leases [Abstract]
Summary of Operating Lease Expense	Total operating lease expense included in the condensed consolidated interim statements of operations and comprehensive loss is as follows:     Three months ended March 31,       2024     2023   Operating lease expense   $ 318,844     $ 400,450   Short term lease expense     36,983       79,563   Variable and other lease expense     110,220       66,528    Total   $ 466,047     $ 546,541
Summary Of Future Minimum Payments Under Non-cancelable Operating Lease Obligations	Future minimum payments under non-cancelable operating lease obligations were as follows as of March 31, 2024:  Remainder of 2024   $ 1,318,116    2025     1,719,548    2026     1,573,802    2027     1,159,226    2028     1,166,646   Thereafter     3,792,436   Total minimum lease payments     10,729,774   Less: interest     (3,761,689 ) Present value of net minimum lease payments     6,968,085   Less: current portion of lease liabilities     (1,296,404 ) Total long-term lease liabilities   $ 5,671,681

v3.24.1.1.u2

Segment and Geographic Information (Tables)	3 Months Ended
	Mar. 31, 2024
Segment Reporting [Abstract]
Summary of net revenues by major geographic area	Our net revenues by major geographic area (based on destination) were as follows:     Three months ended March 31,   Revenue by geography   2024     2023   United States                  Product sales   $ 8,512     $ 11,025        Development revenue     3,141,759       1,257,479        Licensing revenue     24,059       24,075   Canada                  Product sales     53,712       18,935        Licensing revenue     21,270       22,852   Other Countries                  Product sales     22,945       28,739        Licensing revenue     —       49,154   Total revenue   $ 3,272,257     $ 1,412,259
Summary of property plant and equipment net per geographic region	Property, plant and equipment, net per geographic region were as follows:     As of March 31,     As of December 31,   Property, plant and equipment, net   2024     2023   United States   $ —     $ —   Canada     17,603,917       18,333,413   Other countries     244,956       268,201   Total property, plant and equipment, net   $ 17,848,873     $ 18,601,614

v3.24.1.1.u2

Commitments and Contingencies (Tables)	3 Months Ended
	Mar. 31, 2024
Commitments and Contingencies Disclosure [Abstract]
Summary of Contractual Cash Obligations	The following table and discussion summarizes our contractual cash obligations other than the lease payment obligations shown in the Note 17, Leases, as of March 31, 2024, for each of the periods presented:   Long-term debt     Other contractual commitment     Total    Remainder of 2024 $ 663,586     $ 1,146,973     $ 1,810,559    2025   999,789       116,009       1,115,798    2026   1,183,560       29,002       1,212,562    2027   577,081       —       577,081    2028   571,939       —       571,939    Thereafter   705,720       —       705,720   $ 4,701,675     $ 1,291,984     $ 5,993,659

v3.24.1.1.u2

Corporate Information - Additional Information (Details)	3 Months Ended
	Mar. 31, 2024 Patent
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of active patent documents	455
Number of patents have issued	346

v3.24.1.1.u2

Significant Accounting Policies - Additional Information (Details) $ in Millions			3 Months Ended
	Jan. 29, 2024 USD ($) shares	Jan. 26, 2024	Mar. 31, 2024
Accounting Policies [Abstract]
Reverse stock split ratio	0.01	0.01
Reverse stock split		1-for-100	Every one hundred shares of Common Stock issued and outstanding were automatically combined into one
Reclassified common stock to additional paid-in-capital | $	$ 0.5
Reverse stock split fractional shares adjustment | shares	177,686

v3.24.1.1.u2

Significant Accounting Policies - Schedule of Reverse Stock Split (Details) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Class of Stock [Line Items]
Number of shares authorized	10,000,000		10,000,000
Number of shares issues	6,694,635		5,659,438
Number of shares outstanding	6,694,635		5,659,438
Weighted average number of shares outstanding - basic	6,180,363	3,688,793
Weighted average number of shares outstanding - diluted	6,180,363	3,688,793
Basic loss per share	$ (1.21)	$ (5.06)
Diluted loss per share	$ (1.21)	$ (5.06)
Post-Reverse Stock Split [Member]
Class of Stock [Line Items]
Number of shares authorized		10,000,000
Number of shares issues		3,837,449
Number of shares outstanding		3,837,449
Weighted average number of shares outstanding - basic		3,688,793
Weighted average number of shares outstanding - diluted		3,688,793
Basic loss per share		$ (5.06)
Diluted loss per share		$ (5.06)
Pre-Reverse Stock Split [Member]
Class of Stock [Line Items]
Number of shares authorized		1,000,000,000
Number of shares issues		383,744,889
Number of shares outstanding		383,744,889
Weighted average number of shares outstanding - basic		368,879,341
Weighted average number of shares outstanding - diluted		368,879,341
Basic loss per share		$ (0.05)
Diluted loss per share		$ (0.05)

v3.24.1.1.u2

Going Concern - Additional Information (Details) - USD ($)		3 Months Ended		12 Months Ended
	May 02, 2024	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net Income (Loss)		$ (7,508,414)	$ (18,668,678)	$ (398,200,000)
Accumulated deficit		(616,519,947)		(609,011,533)
Working capital earnings (deficit)		7,900,000		6,200,000
Negative cash flows from operating activities		$ (5,922,764)	$ (15,520,162)	$ (42,200,000)
Substantial doubt about going concern, management's evaluation		Our evaluation entails analyzing prospective operating budgets and forecasts for expectations of our cash needs and comparing those needs to the current cash and cash equivalent balances.
Substantial doubt about going concern, within one year		true
Subsequent Event [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Percentage of reduction in workforce	80.00%
Severance payments, benefits and related costs	$ 1,500,000

v3.24.1.1.u2

Realignment and Consolidation Plan - Additional Information (Details) - USD ($)	3 Months Ended	10 Months Ended
	Mar. 31, 2024	Mar. 31, 2024	Dec. 31, 2023
Restructuring and Related Activities [Abstract]
Realignment and consolidation plan, initiation date	Jun. 06, 2023
Restructuring expense	$ 266,035	$ 4,100,000
Restructuring costs accrual	1,008,924	$ 1,008,924	$ 1,182,112
Cash payments for restructuring	$ 400,000

v3.24.1.1.u2

Note Receivable - Additional Information (Details) - USD ($)		1 Months Ended	3 Months Ended		12 Months Ended
	Aug. 07, 2023	Aug. 28, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Jan. 21, 2024	Dec. 14, 2022
Debt Instrument [Line Items]
Aggregate purchase of common stock				$ 10,477,069
Next Bridge Hydrocarbons Inc. [Member] | Loan Sale Agreement [Member] | Gregory McCabe [Member]
Debt Instrument [Line Items]
Cash consideration on sale of notes receivable	$ 6,000,000
Notes receivable	24,000,000
Aggregate purchase of common stock	$ 6,000,000				$ 500,000
Monthly stock purchase amount for first six months		$ 250,000
Monthly stock purchase amount for next nine months thereafter		$ 500,000
Percentage of 5-day VWAP of common stock on trading day preceding date of each purchase		120.00%
Total shares sold of common stock					18,517
Next Bridge Hydrocarbons Inc. [Member] | Release Agreement [Member] | Gregory McCabe [Member]
Debt Instrument [Line Items]
Obligation to receive payment for stock purchase made						$ 700,000
Obligation to receive additional payment for stock purchase made						700,000
Payment received under obligation for stock purchases made						$ 700,000
Total shares sold of common stock			18,517
Treasury stock reissued			$ 100,000
Next Bridge Hydrocarbons Inc. [Member] | 2021 Note [Member]
Debt Instrument [Line Items]
Debt instrument face amount							$ 15,000,000
Next Bridge Hydrocarbons Inc. [Member] | 2022 Note [Member]
Debt Instrument [Line Items]
Debt instrument face amount							$ 5,000,000

v3.24.1.1.u2

Inventory - Summary of Inventory (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Inventory Disclosure [Abstract]
Raw materials	$ 512,897	$ 558,837
Supplies	10,693	10,747
Work in process	36,999	45,912
Finished goods	42,226	43,922
Inventory provision	(478,938)	(490,671)
Total inventory	$ 123,877	$ 168,747

v3.24.1.1.u2

Prepaid Expenses And Other Current Assets - Summary of Prepaid Expenses And Other Current Assets (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Prepaid expenses	$ 1,253,610	$ 1,476,981
Receivable for insurance proceeds (Note 19)	0	3,100,000
Other current assets	257,666	332,794
Taxes receivable	76,216	161,588
Total prepaid expenses and other current assets	$ 1,587,492	$ 5,071,363

v3.24.1.1.u2

Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 61,081,490	$ 62,301,597
Accumulated depreciation and impairment	(43,232,617)	(43,699,983)
Property, plant and equipment, net	17,848,873	18,601,614
Land [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	439,115	449,872
Building [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 5,060,849	5,184,826
Property, Plant and Equipment, Useful Life	25 years
Computer equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 1,550,507	1,583,617
Computer equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Computer equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Computer software [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 796,670	815,777
Property, Plant and Equipment, Useful Life	1 year
Manufacturing equipment [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 23,608,611	23,979,024
Manufacturing equipment [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Manufacturing equipment [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	2 years
Office furniture [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 895,962	914,265
Office furniture [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Office furniture [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Leasehold improvements [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 22,311,365	22,794,726
Leasehold improvements [Member] | Maximum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	10 years
Leasehold improvements [Member] | Minimum [Member]
Property, Plant and Equipment [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Enterprise Resource Planning software [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 197,560	202,400
Property, Plant and Equipment, Useful Life	5 years
Assets under construction [Member]
Property, Plant and Equipment [Line Items]
Property, plant and equipment, gross	$ 6,220,851	$ 6,377,090

v3.24.1.1.u2

Property, Plant and Equipment, Net - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Property, Plant and Equipment [Abstract]
Depreciation	$ 0.3	$ 1.5

v3.24.1.1.u2

Intangible Assets and Goodwill - Schedule of Intangible Assets, Net (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 66,551,275	$ 67,294,055
Accumulated amortization and impairment	(49,614,929)	(49,263,754)
Intangibles, Net	16,936,346	18,030,301
Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 42,862,050	43,025,376
Patents [Member] | Maximum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Useful Life (years)	10 years
Patents [Member] | Minimum [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Useful Life (years)	5 years
Trademarks [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 124,649	126,839
Developed technology [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 13,970,480	14,312,717
Intangibles, Useful Life (years)	20 years
Customer contracts [Member]
Finite-Lived Intangible Assets [Line Items]
Intangibles, Gross	$ 9,594,096	$ 9,829,123
Intangibles, Useful Life (years)	5 years

v3.24.1.1.u2

Intangible Assets and Goodwill - Additional Information - (Details) - USD ($) $ in Millions	3 Months Ended		12 Months Ended
	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 0.7	$ 1.8
Goodwill impairment			$ 282.2

v3.24.1.1.u2

Long-Term Debt - Summary of Long Term Debt (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Debt Instrument [Line Items]
Total debt	$ 3,504,297	$ 3,724,617
Less: current portion	545,215	801,628
Long-term debt	2,959,082	2,922,989
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member]
Debt Instrument [Line Items]
Total debt	1,236,633	1,486,966
ACOA BDP 2018 [Member]
Debt Instrument [Line Items]
Total debt	990,836	1,047,122
ACOA PBS 2019 [Member]
Debt Instrument [Line Items]
Total debt	27,654	29,936
ACOA Regional Relief and Recovery Fund ("RRRF") 2020 [Member]
Debt Instrument [Line Items]
Total debt	135,869	151,070
EDC 2022 [Member]
Debt Instrument [Line Items]
Total debt	$ 1,113,305	$ 1,009,523

v3.24.1.1.u2

Long-Term Debt - Summary of Long Term Debt (Parenthetical) (Details)	3 Months Ended
	Mar. 31, 2024 USD ($)	Mar. 31, 2024 CAD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2024 CAD ($)	Dec. 31, 2023 CAD ($)
Debt Instrument [Line Items]
Revenues	$ 3,272,257		$ 1,412,259
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member]
Debt Instrument [Line Items]
Debt annual principal repayments commencement date	Jun. 01, 2021	Jun. 01, 2021
Maximum contribution				$ 3,000,000
Frequency of payment	Annual	Annual
Amount drawn down				$ 2,122,882	$ 2,481,823
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 1,000,000 [Member]
Debt Instrument [Line Items]
Percentage of annual principal repayments	0.00%	0.00%
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 1,000,000 [Member] | Minimum [Member]
Debt Instrument [Line Items]
Revenues		$ 1,000,000
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 10,000,000 And Greater Than Canadian Dollar 1,000,000 [Member]
Debt Instrument [Line Items]
Percentage of annual principal repayments	5.00%	5.00%
Revenues		$ 10,000,000
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenues Are Less Than Canadian Dollar 10,000,000 And Greater Than Canadian Dollar 1,000,000 [Member] | Maximum [Member]
Debt Instrument [Line Items]
Revenues		10,000,000
ACOA Atlantic Innovation Fund ("AIF") 2015 [Member] | Gross Revenue Are Greater Than Canadian Dollar 10,000,000 [Member]
Debt Instrument [Line Items]
Principal periodic payment		$ 500,000
Percentage of variable annual principal repayment	1.00%	1.00%
Revenues		$ 1,000,000
ACOA BDP 2018 [Member]
Debt Instrument [Line Items]
Long term debt maturity date	May 01, 2029			May 01, 2029
Debt annual principal repayments commencement date	Jun. 01, 2021	Jun. 01, 2021
Maximum contribution				$ 3,000,000
Principal periodic payment		$ 31,250
Frequency of payment	monthly	monthly
Deferred government assistance	$ 425,872
Long Term debt cumulative drawdown amount				$ 1,937,500	2,031,250
ACOA PBS 2019 [Member]
Debt Instrument [Line Items]
Long term debt maturity date	May 01, 2027			May 01, 2027
Debt annual principal repayments commencement date	Jun. 01, 2021	Jun. 01, 2021
Maximum contribution				$ 100,000
Principal periodic payment		$ 1,400
Frequency of payment	monthly	monthly
Long Term debt cumulative drawdown amount				$ 52,778	56,944
ACOA Regional Relief and Recovery Fund ("RRRF") 2020 [Member]
Debt Instrument [Line Items]
Long term debt maturity date	Apr. 01, 2026			Apr. 01, 2026
Debt annual principal repayments commencement date	Apr. 01, 2023	Apr. 01, 2023
Maximum contribution				$ 390,000
Principal periodic payment		$ 11,000
Frequency of payment	monthly	monthly
Long Term debt cumulative drawdown amount				258,000	291,000
EDC 2022 [Member]
Debt Instrument [Line Items]
Debt annual principal repayments commencement date	Jan. 31, 2026	Jan. 31, 2026
Maximum contribution				2,000,000
Principal periodic payment		$ 30,000
Frequency of payment	monthly	monthly
Deferred government assistance				600,000
Long Term debt cumulative drawdown amount				$ 2,000,000	$ 1,800,000
Long-term debt, term	60 months			60 months
EDC 2022 [Member] | Building renovations [Member]
Debt Instrument [Line Items]
Maximum contribution				$ 1,000,000
EDC 2022 [Member] | Equipment [Member]
Debt Instrument [Line Items]
Maximum contribution				$ 1,000,000

v3.24.1.1.u2

Capital Stock - Additional Information (Details) - USD ($)				3 Months Ended
	Feb. 21, 2024	Feb. 19, 2024	Jan. 26, 2024	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Feb. 10, 2023
Class of Stock [Line Items]
Common stock, shares authorized				10,000,000		10,000,000
Common stock, shares par value				$ 0.001		$ 0.001
Offering price				$ 6,694		$ 543,046
Reverse stock split			1-for-100	Every one hundred shares of Common Stock issued and outstanding were automatically combined into one
Share price				$ 60
Non-cash issuance costs as a result of amendment of June 2022 Warrants and December 2023 Warrants				$ 185,331
Letter Agreement [Member]
Class of Stock [Line Items]
Reverse stock split		1-for-100
DSUs [Member]
Class of Stock [Line Items]
Stock units vested and settled equal number of common shares				1,821
Common Stock [Member]
Class of Stock [Line Items]
Total shares sold of common stock					175,740
Common Stock [Member] | Restricted Stock Units (RSUs) [Member]
Class of Stock [Line Items]
Stock units vested and settled equal number of common shares				5,690
At The Market Offering Program [Member] | Sales Agreement [Member]
Class of Stock [Line Items]
Common stock, shares par value							$ 0.001
Total shares sold of common stock					175,740
Gross proceeds from issuance of common stock					$ 10,500,000
Net proceeds from issuance of common stock					$ 10,000,000
At The Market Offering Program [Member] | Maximum [Member] | Sales Agreement [Member]
Class of Stock [Line Items]
Offering price							$ 100,000,000
February 2024 Offering
Class of Stock [Line Items]
Net proceeds from issuance of common stock	$ 3,000,000
February 2024 Offering | Common Stock [Member] | Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Number of shares issued	600,000
Sale of stock combined with warrant, price per share	$ 4.04
Purchase price of per share	0.001
Warrants exercise price	$ 3.91
February 2024 Offering | Pre-Funded Warrant [Member] | Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Number of securities called by warrant	250,000			250,000
Pre - funded warrant combined with warrant price per share	$ 4.039
February 2024 Offering | Warrant [Member] | Securities Purchase Agreement [Member]
Class of Stock [Line Items]
Number of securities called by warrant	850,000
February 2024 Offering | June 2022 Warrant [Member] | Letter Agreement [Member]
Class of Stock [Line Items]
Number of securities called by warrant		74,074
February 2024 Offering | December 2022 Warrant [Member] | Letter Agreement [Member]
Class of Stock [Line Items]
Number of securities called by warrant		25,000
February 2024 Offering | June 2022 Warrant and December 2022 Warrant [Member] | Letter Agreement [Member]
Class of Stock [Line Items]
Non-cash issuance costs as a result of amendment of June 2022 Warrants and December 2023 Warrants				$ 200,000

v3.24.1.1.u2

Capital Stock - Summary of Changes in Warrants (Details) - Warrants [Member]	3 Months Ended
	Mar. 31, 2024 USD ($) shares
Class of Warrant or Right [Line Items]
Balance, beginning of period, shares	1,974,280
Reverse stock split fractional shares adjustment	16
Issued, shares	850,000
Exercised, shares	(250,000)
Balance, end of period, shares	2,574,296
Balance, beginning of period | $	$ 39,269,867
Issued | $	2,017,800
Exercised | $	(589,784)
Balance, end of period | $	$ 40,697,883

v3.24.1.1.u2

Stock-Based Payments - Additional Information (Details)	Dec. 03, 2021 shares
2015 Stock Option and Grant Plan [Member]
Shares reserved for future issuance	35,000
2018 Stock Option and Grant Plan [Member]
Shares reserved for future issuance	64,457
2021 Equity Incentive Plan [Member]
Shares reserved for future issuance	349,457

v3.24.1.1.u2

Stock-Based Payments - Summary of change in outstanding share RSUs (Details)	3 Months Ended
	Mar. 31, 2024 $ / shares shares
DSU Plan [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning of period	50,257
Reverse stock split fractional shares adjustment	14
Redeemed	(1,821)
Outstanding, end of period	48,450
Weighted average grant date fair value, beginning balance | $ / shares	$ 29.57
Weighted average grant date fair value, redeemed | $ / shares	151.32
Weighted average grant date fair value, ending balance | $ / shares	$ 25.03
Restricted Stock Units (RSUs) [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning of period	90,725
Reverse stock split fractional shares adjustment	60
Forfeited	(5,253)
Awards vested and settled	(5,690)
Outstanding, end of period	79,842
Weighted average grant date fair value, beginning balance | $ / shares	$ 49.16
Forfeited, Weighted Average grant date fair value | $ / shares	99.94
Vested and settled, Weighted Average grant date fair value | $ / shares	124.26
Weighted average grant date fair value, ending balance | $ / shares	$ 40.52
Vested, end of period, Number of RSUs	439
Vested, end of period, Weighted Average grant date fair value | $ / shares	$ 121

v3.24.1.1.u2

Stock-Based Payments - Summary of Stock-Based Compensation Expenses (Details) - USD ($)		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses		$ 310,825	$ 1,858,440
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses	[1]	325	1,086,677
Restricted Stock Units (RSUs) [Member] | Cost of Sales [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses		(48,418)	143,905
Restricted Stock Units (RSUs) [Member] | Selling & Marketing
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses		13,439	120,544
Restricted Stock Units (RSUs) [Member] | General & Administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses		61,552	403,207
Restricted Stock Units (RSUs) [Member] | Research & Development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses		(26,248)	419,021
Employee Stock Option Plan [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses	[2]	249,089	915,663
Employee Stock Option Plan [Member] | Selling & Marketing
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses			99,242
Employee Stock Option Plan [Member] | General & Administrative
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses		123,056	499,042
Employee Stock Option Plan [Member] | Research & Development
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total expenses		$ 126,033	$ 317,379
[1] Estimated forfeiture rate for RSUs as of March 31, 2024 is 20% compared to the estimated forfeiture rate of 0% for RSUs as of March 31, 2023. [2] Estimated forfeiture rate for stock options as of March 31, 2024 is 8% compared to the estimated forfeiture rate of 0% for stock options as of March 31, 2023.

v3.24.1.1.u2

Stock-Based Payments - Summary of Stock-Based Compensation Expenses (Parenthetical) (Details)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Restricted Stock Units (RSUs) [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Change in estimated forfeiture rate	20.00%	0.00%
Employee Stock Option Plan [Member]
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Change in estimated forfeiture rate	8.00%	0.00%

v3.24.1.1.u2

Stock-Based Payments - Summary of Change in Share Outstanding Options (Details) - $ / shares	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Outstanding, beginning of period, Number of Options	189,540
Reverse stock split fractional shares adjustment	33
Forfeited, Number of Options	(53,726)
Outstanding, end of period, Number of Options	135,847	189,540
Exercisable, end of period	79,176	121,356
Outstanding, beginning of period, Average exercise price per stock option	$ 62.23
Forfeited, Average exercise price per stock option	63.54
Outstanding, end of period, Average exercise price per stock option	61.72	$ 62.23
Exercisable, end of period	$ 83.95
Outstanding, Average exercise remaining contractual term (years)	7 years 3 months	4 years 8 months 4 days
Exercisable, Average exercise remaining contractual term (years)	5 years 9 months 25 days

v3.24.1.1.u2

Stock-Based Payments - Summary of Stock Options Outstanding (Details) - $ / shares	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Schedule of Stock Options Outstanding [Line Items]
Number outstanding	135,847	189,540
Number exercisable	79,176	121,356
$12.00 - $27.00 [Member]
Schedule of Stock Options Outstanding [Line Items]
Range of exercise price, minimum	$ 12
Range of exercise price, maximum	$ 27
Number outstanding	93,070	124,383
Number exercisable	44,641	75,457
$89.00 - $100.00 [Member]
Schedule of Stock Options Outstanding [Line Items]
Range of exercise price, minimum	$ 89
Range of exercise price, maximum	$ 100
Number outstanding	4,200	14,918
Number exercisable	4,200	11,793
$117.00 - $126.00 [Member]
Schedule of Stock Options Outstanding [Line Items]
Range of exercise price, minimum	$ 117
Range of exercise price, maximum	$ 126
Number outstanding	10,376	15,029
Number exercisable	5,294	8,446
$131.00 - $158.00 [Member]
Schedule of Stock Options Outstanding [Line Items]
Range of exercise price, minimum	$ 131
Range of exercise price, maximum	$ 158
Number outstanding	17,451	24,460
Number exercisable	14,291	16,286
$197.00 - 200.00 [Member]
Schedule of Stock Options Outstanding [Line Items]
Range of exercise price, minimum	$ 197
Range of exercise price, maximum	$ 200
Number outstanding	10,750	10,750
Number exercisable	10,750	9,374

v3.24.1.1.u2

Net Loss Per Share - Summary Basic and Diluted Net Loss Per Share (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Numerator:
Net loss	$ (7,508,414)	$ (18,668,678)
Denominator:
Weighted-average shares, basic	6,180,363	3,688,793
Weighted-average shares, diluted	6,180,363	3,688,793
Net loss per share
Basic	$ (1.21)	$ (5.06)
Diluted	$ (1.21)	$ (5.06)

v3.24.1.1.u2

Net Loss Per Share - Summary of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,838,435	797,546
Options [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	135,847	308,105
Warrants [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	2,574,296	399,209
RSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	79,842	51,130
DSUs [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	48,450	39,102

v3.24.1.1.u2

Additional Cash Flow Information - Summary of Cash Flow, Operating Capital (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Increase (Decrease) in Operating Capital [Abstract]
Inventory	$ 40,970	$ 8,812
Accounts receivables and other receivables	(420,278)	66,159
Prepaid expenses and other current assets	3,452,656	(792,684)
Trade payables, accruals and other accruals	(3,578,613)	(1,687,578)
Restructuring costs accrual	(425,169)
Due from related party	29,906	(60)
Operating lease liabilities	(373,421)	(318,919)
Total	$ (1,273,949)	$ (2,724,270)

v3.24.1.1.u2

Fair Value Measurements - Summary of Fair Value of Financial Instruments (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Operating lease liabilities	$ 6,968,085
Long-term debt	3,504,297	$ 3,724,617
Carrying Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Funding obligation	959,410	982,912
Operating lease liabilities	6,968,085	7,426,520
Long-term debt	3,504,297	3,724,617
Fair Value [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Funding obligation	959,410	982,912
Operating lease liabilities	9,315,009	9,782,069
Long-term debt	$ 3,764,136	$ 3,970,061

v3.24.1.1.u2

Revenue - Additional Information (Details)		3 Months Ended
		Mar. 31, 2024 USD ($) Segment Customer	Mar. 31, 2023 USD ($) Customer	Sep. 30, 2023 USD ($)	Aug. 31, 2023 USD ($)
Disaggregation of Revenue [Line Items]
Number of operating segment | Segment		1
Total revenue		$ 3,272,257	$ 1,412,259
Development contract value		$ 22,700,000		$ 6,200,000	$ 2,100,000
Contract revenue [Member]
Disaggregation of Revenue [Line Items]
Number of major customers | Customer		2	1
Total revenue	[1]	$ 2,616,759	$ 1,257,479
Contract revenue [Member] | A G10 Central Bank [Member]
Disaggregation of Revenue [Line Items]
Total revenue			$ 1,300,000
Contract revenue [Member] | Customer One [Member]
Disaggregation of Revenue [Line Items]
Total revenue		2,600,000
Contract revenue [Member] | Customer Two [Member]
Disaggregation of Revenue [Line Items]
Total revenue		$ 400,000
Contract revenue [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | A G10 Central Bank [Member]
Disaggregation of Revenue [Line Items]
Concentration risk, percentage			89.10%
Contract revenue [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Two Customers [Member] | Minimum [Member]
Disaggregation of Revenue [Line Items]
Concentration risk, percentage		10.00%
Contract revenue [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member]
Disaggregation of Revenue [Line Items]
Concentration risk, percentage		79.80%
Contract revenue [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer Two [Member]
Disaggregation of Revenue [Line Items]
Concentration risk, percentage		11.50%
[1] A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones.

v3.24.1.1.u2

Revenue - Summary of Revenue Disaggregated (Details) - USD ($)		3 Months Ended
		Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 3,272,257	$ 1,412,259
Product sales [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		85,169	58,699
Licensing revenue
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		45,329	96,081
Contract revenue [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax	[1]	2,616,759	1,257,479
Other development revenue [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		525,000
Development revenue [Member]
Disaggregation of Revenue [Line Items]
Revenue from Contract with Customer, Excluding Assessed Tax		$ 3,141,759	$ 1,257,479
[1] A portion of contract revenue represents previously recorded deferred revenue that was recognized as revenue after satisfaction of performance obligations either through passage of time or after completion of specific performance milestones.

v3.24.1.1.u2

Leases - Additional Information (Details)		3 Months Ended
	Jan. 15, 2024 USD ($)	Mar. 31, 2024 USD ($) Agreement	Mar. 31, 2023 Agreement
Number of lease agreements | Agreement		0	0
Derecognized lease liability	$ 300,000
Derecognized ROU assets	$ 300,000	$ 250,878

v3.24.1.1.u2

Leases - Summary of Operating Lease Expense (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Lease, Cost [Abstract]
Operating lease expense	$ 318,844	$ 400,450
Short term lease expense	36,983	79,563
Variable and other lease expense	110,220	66,528
Total	$ 466,047	$ 546,541

v3.24.1.1.u2

Leases - Summary of Future Minimum Payments Under Non-cancelable Operating Lease Obligations (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract]
Remainder of 2024	$ 1,318,116
2025	1,719,548
2026	1,573,802
2027	1,159,226
2028	1,166,646
Thereafter	3,792,436
Total minimum lease payments	10,729,774
Less: interest	(3,761,689)
Present value of net minimum lease payments	6,968,085
Less: current portion of lease liabilities	(1,296,404)	$ (1,452,863)
Total long-term lease liabilities	$ 5,671,681	$ 5,973,657

v3.24.1.1.u2

Segment and Geographic Information - Schedule Net Revenues by Major Geographic Area (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Disaggregation of Revenue [Line Items]
Total revenue	$ 3,272,257	$ 1,412,259
Product sales
Disaggregation of Revenue [Line Items]
Total revenue	85,169	58,699
Development revenue
Disaggregation of Revenue [Line Items]
Total revenue	3,141,759	1,257,479
Licensing revenue
Disaggregation of Revenue [Line Items]
Total revenue	45,329	96,081
United States | Product sales
Disaggregation of Revenue [Line Items]
Total revenue	8,512	11,025
United States | Development revenue
Disaggregation of Revenue [Line Items]
Total revenue	3,141,759	1,257,479
United States | Licensing revenue
Disaggregation of Revenue [Line Items]
Total revenue	24,059	24,075
Canada | Product sales
Disaggregation of Revenue [Line Items]
Total revenue	53,712	18,935
Canada | Licensing revenue
Disaggregation of Revenue [Line Items]
Total revenue	21,270	22,852
Other countries | Product sales
Disaggregation of Revenue [Line Items]
Total revenue	22,945	28,739
Other countries | Licensing revenue
Disaggregation of Revenue [Line Items]
Total revenue	$ 0	$ 49,154

v3.24.1.1.u2

Segment and Geographic Information - Schedule of Property Plant and Equipment Net per Geographic Region (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 17,848,873	$ 18,601,614
United States
Segment Reporting Information [Line Items]
Property, plant and equipment, net
Canada
Segment Reporting Information [Line Items]
Property, plant and equipment, net	17,603,917	18,333,413
Other countries
Segment Reporting Information [Line Items]
Property, plant and equipment, net	$ 244,956	$ 268,201

v3.24.1.1.u2

Segment and Geographic Information (Additional Information) (Details)	3 Months Ended
	Mar. 31, 2024 Segment
Segment Reporting [Abstract]
Number of operating segment	1
Number of reportable segment	1

v3.24.1.1.u2

Commitments and Contingencies - Additional Information (Details) $ in Millions							1 Months Ended	3 Months Ended
	Dec. 20, 2023 USD ($)	Sep. 29, 2023	Sep. 21, 2023 USD ($)	Nov. 01, 2022	Jul. 05, 2022 USD ($)	Jan. 15, 2021 USD ($) Patent	Sep. 30, 2022 USD ($) Pounds	Mar. 31, 2024 USD ($) Installment	Mar. 25, 2024 USD ($)	Feb. 08, 2024 CAD ($)	Dec. 31, 2023 USD ($)	Mar. 31, 2022	Dec. 31, 2018 USD ($)
Payments of civil money penalty amount								$ 1,000,000
Number of installments in civil money penalty amount | Installment								4
Accruals and other payables								$ 3,841,799			$ 7,249,291
Royalties								0
Accruals and Other Payables [Member]
Payments of civil money penalty amount								1,000,000
Amended Supply Agreement [Member]
Purchase obligation, agreement period				3 years
Non-cancelable orders								300,000
WestPark Capital Group, LLC [Member] | Accruals and Other Payables [Member]
Litigation liability								300,000
Nevada Shareholder Action [Member]
Litigation settlement, amount awarded to other party			$ 3,000,000
Insurance recoveries			$ 2,850,000
American Paint and Coatings Company [Member] | Minimum Purchase Obligation [Member]
Raw materials purchased | Pounds							20,000
Purchase obligation, agreement period							3 years
Minimum purchase obligation							$ 1,100,000
Non-cancelable orders								700,000
Accruals and other payables								400,000
Vlepsis Technology [Member]
Percentage of net profit equilavant of allocate bonus pool												50.00%
RBC [Member] | Satair [Member] | Letter of Credit [Member]
Line of credit facility, maximum borrowing capacity													$ 500,000
Breach of Contract [Member] | MRS Constructions Limited [Member]
Litigation fees claim										$ 1.0
Trade payables								500,000
Breach of Contract [Member] | Sustainable Development Technology Canada [Member]
Litigation fees claim									$ 200,000
Breach of Contract [Member] | Sustainable Development Technology Canada [Member] | Accruals and Other Payables [Member]
Litigation fees claim								$ 200,000
Breach of Contract [Member] | WestPark Capital Group, LLC [Member]
Monetary relief, sought value					$ 500,000
Securities Class Action [Member]
Loss contingency, trial								Lead plaintiffs filed a consolidated complaint on August 29, 2022. We moved to dismiss that complaint on October 13, 2022. The Court granted our motion to dismiss on September 29, 2023 and entered judgment on the defendants' behalf on October 3, 2023. On October 27, 2023, the lead plaintiffs filed a motion to vacate judgment and for leave to amend the pleadings. On October 27, 2023, the lead plaintiffs filed a motion to vacate judgment and for leave to amend the pleadings.
Loss contingency, date of dismissal		Sep. 29, 2023
Litigation settlement, amount awarded to other party	$ 3,000,000
Insurance recoveries								$ 2,850,000
Legal settlement payment								$ 3,000,000
Nanotech Security Corp [Member]
Number of patents purchased | Patent						6
Revenue related to patents purchased						$ 100,000
Revenue from Specific Customer [Member]
Percentage share of revenue related to patents						10.00%
Number of years revenue shared						2 years
Other Revenue [Member]
Number of years royalties shared						5 years
Other Revenue [Member] | Maximum [Member]
Percentage of royalties on other revenues related to patents						6.00%
Other Revenue [Member] | Minimum [Member]
Percentage of royalties on other revenues related to patents						3.00%

v3.24.1.1.u2

Commitments and Contingencies - Summary of Contractual Cash Obligations (Details)	Mar. 31, 2024 USD ($)
Long-Term Debt [Member]
Loss Contingencies [Line Items]
Remainder of 2024	$ 663,586
2025	999,789
2026	1,183,560
2027	577,081
2028	571,939
Thereafter	705,720
Contractual obligation	4,701,675
Other Contractual Commitment [Member]
Loss Contingencies [Line Items]
Remainder of 2024	1,146,973
2025	116,009
2026	29,002
Contractual obligation	1,291,984
Contractual Cash Obligations [Member]
Loss Contingencies [Line Items]
Remainder of 2024	1,810,559
2025	1,115,798
2026	1,212,562
2027	577,081
2028	571,939
Thereafter	705,720
Contractual obligation	$ 5,993,659

v3.24.1.1.u2

Subsequent Events - Additional Information (Details)	May 02, 2024
Subsequent Event [Member]
Subsequent Event [Line Items]
Percentage of reduction in workforce	80.00%

---